Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
1002102	s-hcg-b-v	ug/l (ug/l)	10521	15966	0.00%
1002102	s-hcg-b-v	µg/l (ug/l)	5	5	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Complications of labour and delivery

2176

4802

2.62

308.22

1.6

1.5

60.07

60.14

ug/l

0.02

2176

4802

Other obstetric conditions, not elsewhere classified

2763

6630

2.93

307.65

1.6

1.5

60.04

60.02

ug/l

0.01

2763

6630

Delivery, wide proxy

1646

166

58.12

307.65

1.6

1.1

60.57

63.12

ug/l

0.14

1646

166

Single delivery by forceps and vacuum extractor

1104

226

34.04

307.65

1.6

1.1

62.60

63.74

ug/l

0.07

1104

226

Prolonged pregnancy

1294

2417

5.25

307.65

1.6

1.4

62.47

60.08

ug/l

0.85

1294

2417

Other maternal disorders predominantly related to pregnancy

2765

4846

3.82

307.65

1.6

1.5

57.62

63.10

ug/l

6.75

2765

4846

Pregnancy, childbirth and the puerperium

1306

100.68

307.65

1.6

1.0

59.70

64.37

ug/l

0.33

1306

Procreative management

708

476

12.69

307.65

1.6

1.4

61.69

60.83

ug/l

0.10

708

476

Single delivery by caesarean section

1309

238

36.39

307.65

1.5

1.1

57.48

63.57

ug/l

0.58

1309

238

Diabetes mellitus in pregnancy

2463

4738

3.67

307.65

1.6

1.5

54.28

63.27

ug/l

17.69

2463

4738

Gestational diabetes (for exclusion)

2644

7200

2.76

307.65

1.6

1.5

53.21

62.81

ug/l

24.80

2644

7200

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2754

6626

2.92

307.65

1.6

1.5

60.28

60.02

ug/l

0.10

2754

6626

Maternal care for other known or suspected fetal problems

1855

2586

5.09

307.65

1.6

1.4

58.78

59.86

ug/l

0.36

1855

2586

Maternal care for known or suspected abnormality of pelvic organs

1512

2347

4.78

307.65

1.7

1.4

56.44

60.28

ug/l

2.23

1512

2347

Maternal care related to the fetus and amniotic cavity and possible delivery problems

2280

2659

5.45

307.65

1.6

1.4

60.57

59.87

ug/l

0.23

2280

2659

Supervision of high-risk pregnancy

1427

474

20.78

307.65

1.6

1.4

58.99

61.02

ug/l

0.30

1427

474

Postpartum care and examination

1818

475

31.78

307.65

1.6

1.4

59.43

61.01

ug/l

0.23

1818

475

Persons encountering health services in circumstances related to reproduction

1202

487

17.12

307.65

1.6

1.4

60.16

60.43

ug/l

0.03

1202

487

Pregnancy examination and test

1039

479

15.27

307.65

1.6

1.4

57.22

60.77

ug/l

0.63

1039

479

Maternal care for known or suspected malpresentation of fetus

1290

2239

4.58

307.65

1.6

1.4

58.65

59.90

ug/l

0.37

1290

2239

Antenatal screening

1229

483

15.75

307.65

1.6

1.4

60.25

60.58

ug/l

0.04

1229

483

Single spontaneous delivery

1657

250

38.04

307.65

1.6

1.1

60.62

62.64

ug/l

0.16

1657

250

Abnormal findings on antenatal screening of mother

1315

2764

6.55

307.65

1.7

1.4

60.80

64.09

ug/l

1.27

1315

2764

Supervision of normal pregnancy

1232

483

16.19

307.65

1.6

1.4

60.76

60.58

ug/l

0.02

1232

483

False labour

2154

2610

5.76

307.65

1.7

1.4

60.08

59.92

ug/l

0.05

2154

2610

Delivery

1732

252

39.49

307.65

1.6

1.1

60.48

62.79

ug/l

0.18

1732

252

Premature rupture of membranes

1739

2479

5.72

307.65

1.6

1.4

59.10

59.92

ug/l

0.26

1739

2479

Postpartum haemorrhage

1454

4437

2.91

269.39

1.6

1.5

64.29

60.45

ug/l

2.14

1454

4437

Maternal care for known or suspected fetal abnormality and damage

926

2237

3.83

266.84

1.8

1.4

60.65

59.98

ug/l

0.15

926

2237

Labour and delivery complicated by fetal stress [distress]

1695

4434

2.71

253.94

1.6

1.5

58.99

60.39

ug/l

0.60

1695

4434

Other disorders of amniotic fluid and membranes

797

2133

3.95

248.54

1.6

1.4

57.08

60.22

ug/l

1.18

797

2133

Contraceptive management

458

481

6.77

246.85

1.6

1.4

55.73

60.75

ug/l

0.88

458

481

Long labour

1309

4133

2.88

240.45

1.5

59.36

60.27

ug/l

0.31

1309

4133

Maternal care for other conditions predominantly related to pregnancy

1194

4215

2.98

239.34

1.6

1.4

60.20

63.38

ug/l

1.56

1194

4215

Multiple delivery

158

25.42

224.79

1.6

1.0

73.54

53.26

ug/l

2.49

158

Polyhydramnios

372

695

6.30

196.21

1.7

1.4

60.04

57.55

ug/l

0.42

372

695

Pre-eclampsia or poor fetal growth

1510

7289

2.18

158.05

1.6

1.5

59.48

60.32

ug/l

0.29

1510

7289

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1713

7527

2.05

152.59

1.5

55.22

61.08

ug/l

6.80

1713

7527

Pregnancy hypertension

1647

7467

2.05

147.55

1.5

55.00

61.08

ug/l

7.09

1647

7467

Haemorrhage in early pregnancy

951

3805

2.53

144.39

1.6

1.4

56.20

63.60

ug/l

5.53

951

3805

Other abnormal products of conception

1631

5689

1.97

121.33

1.7

1.5

56.25

61.78

ug/l

4.84

1631

5689

Obstructed labour due to malposition and malpresentation of fetus

929

3809

2.37

119.71

1.5

58.49

60.16

ug/l

0.56

929

3809

Poor fetal growth

942

4399

2.36

112.84

1.7

1.5

62.11

59.46

ug/l

0.90

942

4399

Perineal laceration during delivery

1127

4467

2.19

112.00

1.5

62.35

60.52

ug/l

0.65

1127

4467

Spontaneous abortion

1632

5960

1.89

110.93

1.7

1.5

57.26

61.73

ug/l

3.37

1632

5960

Persons encountering health services for specific procedures and health care

696

9360

0.43

104.56

1.5

58.48

60.25

ug/l

0.54

696

9360

Gestational [pregnancy-induced] hypertension

1162

5944

2.05

104.23

1.6

1.5

55.04

61.04

ug/l

5.23

1162

5944

Antepartum haemorrhage, not elsewhere classified

371

1116

3.56

102.72

1.6

1.4

64.52

58.87

ug/l

1.18

371

1116

Medical treatment for female infertility

1149

5932

2.03

99.20

1.5

59.90

60.07

ug/l

0.05

1149

5932

Postpartum hemorraghe, all women as controls

1454

8029

1.86

96.44

1.6

1.5

64.29

59.68

ug/l

3.25

1454

8029

Personal history of other diseases and conditions

626

2598

2.58

95.38

1.8

1.5

58.14

59.53

ug/l

0.34

626

2598

Use of hypnotics and sedatives

425

6429

0.37

91.44

1.4

1.5

58.56

59.99

ug/l

0.29

425

6429

Multiple gestation

322

951

3.58

91.26

1.5

1.4

78.08

58.98

ug/l

6.44

322

951

Twin gestation

312

915

3.61

89.41

1.6

1.4

76.51

59.30

ug/l

6.16

312

915

Preterm labour and delivery

591

2493

2.44

85.23

1.6

1.5

61.65

59.97

ug/l

0.32

591

2493

Factors influencing health status and contact with health services

217

195

5.63

85.04

1.6

1.4

54.83

64.81

ug/l

0.98

217

195

Other assisted single delivery

27.59

81.13

1.5

1.0

60.95

48.76

ug/l

0.68

Pregnancy with abortive outcome

2010

6555

1.63

78.60

1.6

1.5

57.28

61.61

ug/l

4.02

2010

6555

Labour and delivery complicated by umbilical cord complications

225

594

4.13

76.27

1.5

57.21

60.54

ug/l

0.49

225

594

Placenta praevia

217

569

4.15

74.28

1.6

1.4

59.98

57.13

ug/l

0.38

217

569

Contact with and exposure to communicable diseases

1339

7932

1.74

73.30

1.6

1.5

61.03

59.99

ug/l

0.36

1339

7932

Statin medication

258

4368

0.33

73.28

1.3

1.5

58.64

59.66

ug/l

0.14

258

4368

Any event in cancer register

602

7379

0.47

72.34

1.4

1.5

60.79

60.16

ug/l

0.13

602

7379

Special screening examination for infectious and parasitic diseases

206

4929

0.30

72.04

1.4

1.5

62.07

61.07

ug/l

0.15

206

4929

Benzodiazepine use

713

9405

0.51

69.84

1.4

1.5

58.20

60.35

ug/l

0.67

713

9405

ILD medications: prednisolone, methylprednisolone, prednisone

880

8972

0.54

68.82

1.5

56.79

60.43

ug/l

2.04

880

8972

Tramadol

300

4856

0.37

67.48

1.4

1.5

55.01

60.69

ug/l

1.44

300

4856

Any operation in hilmo

28.02

65.76

1.6

1.4

48.40

58.65

ug/l

0.62

Finngen Rheumatological endpoints

838

8719

0.54

65.66

1.5

59.20

60.26

ug/l

0.27

838

8719

Pre-eclampsia

675

3405

2.06

63.08

1.6

1.5

56.07

60.54

ug/l

2.01

675

3405

Pre-eclampsia or eclampsia

682

3468

2.04

62.16

1.6

1.5

55.96

60.71

ug/l

2.24

682

3468

Persons with potential health hazards related to communicable diseases

1364

8474

1.64

60.30

1.6

1.5

60.92

60.01

ug/l

0.31

1364

8474

Diseases of oesophagus, stomach and duodenum

674

7585

0.52

60.26

1.5

57.16

60.44

ug/l

1.19

674

7585

Exclusions for E4_PCOS_CONSORTIUM

756

8568

0.54

58.30

1.5

60.76

60.27

ug/l

0.11

756

8568

Persons encountering health services for other counselling and medical advice, not elsewhere classified

835

7829

0.56

56.66

1.5

60.30

60.37

ug/l

0.02

835

7829

Malignant neoplasm, including Hilmo

266

4068

0.38

56.45

1.4

1.5

62.30

59.14

ug/l

0.59

266

4068

Malignant neoplasm, wide definition

262

4022

0.38

56.15

1.4

1.5

62.66

59.19

ug/l

0.66

262

4022

Oral corticosteroids

802

8329

0.56

55.74

1.5

56.61

60.49

ug/l

2.13

802

8329

Metabolic disorders

285

4321

0.39

55.42

1.5

63.33

59.29

ug/l

0.77

285

4321

Diabetes, insulin treatment (Kela reimbursement)

290

4303

0.40

54.56

1.4

1.5

58.09

59.31

ug/l

0.17

290

4303

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

290

4228

0.40

52.73

1.4

1.5

58.09

60.30

ug/l

0.35

290

4228

Other bacterial diseases, including avohilmo

569

6816

0.52

52.28

1.5

56.03

60.35

ug/l

1.87

569

6816

Other complications of labour and delivery, not elsewhere classified

808

4095

1.86

52.24

1.5

55.72

60.55

ug/l

3.19

808

4095

Pain in throat and chest

666

7215

0.54

52.15

1.5

56.38

60.68

ug/l

2.19

666

7215

Malignant neoplasm

222

3559

0.36

51.76

1.4

1.5

63.26

58.98

ug/l

0.78

222

3559

Malignant neoplasm

219

3526

0.36

51.53

1.5

63.74

58.95

ug/l

0.90

219

3526

All pneumoniae

782

8840

0.57

51.43

1.5

57.42

60.43

ug/l

1.36

782

8840

Solid cancers, including Hilmo

242

3693

0.38

51.10

1.4

1.5

63.21

59.02

ug/l

0.79

242

3693

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

294

1152

2.70

50.93

1.5

50.63

59.67

ug/l

3.07

294

1152

Other nutritional deficiencies

1465

8805

1.54

50.75

1.6

1.5

45.42

62.45

ug/l

69.19

1465

8805

Pneumonias (Asthma/COPD co-morbidities)

775

8773

0.57

50.26

1.5

57.37

60.42

ug/l

1.38

775

8773

Influenza and pneumonia

943

9526

0.60

48.56

1.5

57.14

60.35

ug/l

1.75

943

9526

ILD medications

1097

9334

0.63

47.52

1.5

57.39

60.40

ug/l

1.57

1097

9334

Solid cancers

199

3211

0.36

47.01

1.4

1.5

64.34

58.70

ug/l

1.02

199

3211

Excessive vomiting in pregnancy

323

1374

2.48

46.99

1.5

62.00

62.91

ug/l

0.13

323

1374

Symptoms and signs involving cognition, perception, emotional state and behaviour

632

7552

0.55

46.06

1.5

58.09

60.37

ug/l

0.72

632

7552

Non-invasive ventilation

546

2438

1.97

45.59

1.5

60.95

62.71

ug/l

0.37

546

2438

Artrosis, including avohilmo

256

3409

0.41

45.24

1.4

1.5

56.37

59.14

ug/l

0.38

256

3409

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

730

8289

0.58

44.60

1.5

57.84

60.46

ug/l

1.04

730

8289

Other diseases of intestines

1088

9437

0.64

44.48

1.5

58.41

60.24

ug/l

0.72

1088

9437

Female infertility

1355

5390

1.55

43.76

1.5

58.61

60.04

ug/l

0.58

1355

5390

Infections of genitourinary tract in pregnancy

364

1689

2.26

43.11

1.5

54.02

63.19

ug/l

4.24

364

1689

Dentofacial anomalies [including malocclusion]

1573

8472

1.47

42.75

1.5

61.66

59.74

ug/l

0.87

1573

8472

Diabetes, varying definitions

812

7746

0.60

42.43

1.6

1.5

51.48

61.17

ug/l

10.22

812

7746

Iron deficiency

252

1027

2.77

42.17

1.7

1.5

59.09

62.14

ug/l

0.58

252

1027

Diabetes mellitus

833

7850

0.61

42.05

1.6

1.5

51.25

61.21

ug/l

11.07

833

7850

Inflammatory bowel disease treatment related agents

1084

9258

0.64

42.00

1.5

57.37

60.40

ug/l

1.75

1084

9258

Acute upper respiratory infections of multiple and unspecified sites

1494

7479

1.47

40.64

1.5

57.40

60.80

ug/l

2.28

1494

7479

Family history of certain disabilities and chronic diseases leading to disablement

258

1068

2.59

40.45

1.9

1.5

56.52

60.06

ug/l

0.55

258

1068

Examination and observation for other reasons

465

4949

0.52

40.44

1.4

1.5

55.87

61.03

ug/l

1.58

465

4949

Personality disorders, excluding more controls

281

6115

0.45

40.02

1.4

1.5

57.16

60.45

ug/l

0.66

281

6115

Fall on same level

1169

9357

0.66

39.90

1.5

58.80

60.21

ug/l

0.51

1169

9357

Sleep apnoea, including avohilmo

416

4891

0.51

39.86

1.4

1.5

54.51

59.86

ug/l

1.94

416

4891

Cardiovascular diseases (excluding rheumatic etc)

994

8722

0.64

38.53

1.5

58.73

60.39

ug/l

0.61

994

8722

First line medication for Crohn's disease

1149

9225

0.66

38.11

1.5

57.40

60.42

ug/l

1.81

1149

9225

Persons encountering health services in other circumstances, wide

1001

7829

0.65

36.32

1.5

61.14

60.37

ug/l

0.22

1001

7829

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

597

6835

0.58

35.87

1.5

59.19

60.27

ug/l

0.24

597

6835

Pneumonia, organism unspecified

608

7034

0.59

35.81

1.5

57.71

60.51

ug/l

1.00

608

7034

Pain in limb

856

8471

0.64

35.72

1.5

56.18

60.43

ug/l

2.43

856

8471

Nerve, nerve root and plexus disorders

769

7370

0.62

35.44

1.4

1.5

57.59

60.44

ug/l

1.08

769

7370

Disorders of adult personality and behaviour

297

6084

0.48

35.39

1.4

1.5

57.13

60.50

ug/l

0.72

297

6084

All kidney diseases

899

9180

0.65

33.99

1.5

61.40

60.02

ug/l

0.42

899

9180

Retained placenta and membranes, without haemorrhage

254

1121

2.33

33.50

1.7

1.5

66.30

59.77

ug/l

1.16

254

1121

Female infertility, associated with anovulation

585

3503

1.78

33.26

1.5

58.99

60.54

ug/l

0.34

585

3503

Codeine or tramadol medication

1156

9070

0.69

32.34

1.5

57.24

60.51

ug/l

1.74

1156

9070

Obesity, other/unspecified

767

4883

1.60

31.76

1.6

1.5

42.48

62.02

ug/l

54.28

767

4883

Female infertility, cervical, vaginal, other or unspecified origin

1174

5188

1.49

31.57

1.5

59.00

60.24

ug/l

0.45

1174

5188

Hypertensive diseases

240

2914

0.46

31.10

1.5

56.93

59.45

ug/l

0.37

240

2914

Sleep apnoea

270

3501

0.48

30.95

1.4

1.5

54.35

59.73

ug/l

1.28

270

3501

Hypertension

240

2903

0.46

30.79

1.5

56.93

59.51

ug/l

0.38

240

2903

Other bacterial diseases

412

4905

0.55

30.71

1.5

56.26

60.43

ug/l

1.39

412

4905

Other antidepressants

975

7357

0.67

30.68

1.4

1.6

57.77

60.39

ug/l

1.17

975

7357

Other heart diseases, wide

782

7274

0.65

30.53

1.5

60.15

60.09

ug/l

0.01

782

7274

Personality disorders

281

5569

0.49

30.40

1.4

1.5

57.16

60.63

ug/l

0.71

281

5569

Codeine

1127

8732

0.69

30.34

1.5

57.03

60.71

ug/l

2.08

1127

8732

Postpartum hemorraghe, parous women as controls

1454

8899

1.41

30.16

1.6

1.5

64.29

59.33

ug/l

3.77

1454

8899

Other intervertebral disc disorders

537

5343

0.59

30.00

1.5

59.81

60.39

ug/l

0.09

537

5343

Any mental disorder

1016

7436

0.68

29.99

1.5

59.01

60.33

ug/l

0.46

1016

7436

Hyperkinetic disorders, excluding more controls

312

5480

0.51

29.81

1.4

1.6

61.07

60.65

ug/l

0.06

312

5480

Type 2 diabetes

719

6476

0.64

29.55

1.6

1.5

48.68

60.86

ug/l

14.79

719

6476

Periodontitis

544

5737

0.60

29.50

1.5

58.19

59.72

ug/l

0.33

544

5737

Chronic periodontitis, including avohilmo

541

5706

0.60

29.23

1.5

58.16

59.73

ug/l

0.34

541

5706

Autoimmune diseases excluding thyroid diseases, strict definition

1015

8014

0.68

29.22

1.5

60.15

60.24

ug/l

0.02

1015

8014

Hypertensive diseases (excluding secondary)

240

2913

0.48

28.70

1.5

56.93

59.30

ug/l

0.34

240

2913

Autoimmune diseases excluding thyroid diseases

1037

8099

0.69

28.67

1.5

60.07

60.24

ug/l

0.04

1037

8099

Polyarthropathies

438

4870

0.57

28.52

1.5

59.48

60.77

ug/l

0.27

438

4870

Substance abuse, excluding more controls

384

5716

0.56

28.40

1.4

1.5

56.84

60.51

ug/l

0.97

384

5716

Premature separation of placenta [abruptio placentae]

204

4.13

27.72

1.8

1.4

62.52

62.71

ug/l

0.01

204

Arthrosis

152

2042

0.41

27.64

1.4

1.5

54.96

60.09

ug/l

0.57

152

2042

Diabetes medication

902

7721

0.68

27.59

1.6

1.5

50.79

61.33

ug/l

13.35

902

7721

Specific personality disorders

254

5032

0.49

27.58

1.5

56.25

60.60

ug/l

0.98

254

5032

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

797

6982

0.66

27.45

1.5

57.12

61.07

ug/l

2.11

797

6982

797

6982

0.66

27.45

1.5

57.12

61.07

ug/l

2.11

797

6982

Intracranial trauma

672

6981

0.64

26.83

1.5

55.86

60.94

ug/l

2.83

672

6981

Dental pulpitis, including avohilmo

1773

8612

1.33

26.12

1.5

56.70

60.86

ug/l

3.63

1773

8612

Abnormalities of breathing

1027

8318

0.70

25.98

1.5

58.31

60.62

ug/l

1.08

1027

8318

Other obstructed labour

189

825

2.37

25.87

1.6

1.5

55.82

60.52

ug/l

0.82

189

825

Tonsillectomy and adenotomy

1581

8264

1.35

25.61

1.5

57.86

60.80

ug/l

1.85

1581

8264

Atopic dermatitis

1413

8336

1.36

25.46

1.5

61.69

59.56

ug/l

0.87

1413

8336

Generalized anxiety disorder

289

5320

0.53

25.39

1.5

61.65

60.60

ug/l

0.18

289

5320

Hypertension, essential

217

2543

0.48

25.37

1.5

55.30

59.58

ug/l

0.73

217

2543

Shoulder lesions

220

2692

0.49

24.73

1.4

1.5

56.12

59.65

ug/l

0.73

220

2692

Schizophrenia or delusion, excluding more controls

177

3791

0.46

24.66

1.5

51.28

60.83

ug/l

2.70

177

3791

Type 2 diabetes, definitions combined, including avohilmo

634

5610

0.65

24.20

1.6

1.5

46.27

60.96

ug/l

24.05

634

5610

Infections with a predominantly sexual mode of transmission

445

7234

0.60

24.15

1.6

1.5

61.14

60.38

ug/l

0.14

445

7234

Emotionally unstable personality disorder

163

3552

0.44

23.85

1.4

1.5

55.54

59.99

ug/l

0.72

163

3552

Constipation

399

4554

0.59

23.50

1.4

1.5

59.52

60.18

ug/l

0.10

399

4554

Antihypertensive medication - note that there are other indications

1277

8955

0.74

23.15

1.4

1.5

56.90

60.50

ug/l

2.32

1277

8955

General examination and investigation of persons without complaint and reported diagnosis

629

4949

0.65

22.75

1.5

59.11

61.03

ug/l

0.48

629

4949

Condition for Implicit Sepsis (Organ dysfunction codes)

481

5319

0.62

22.72

1.5

59.06

59.84

ug/l

0.14

481

5319

Maternal care for cervical incompetence

150

638

2.50

22.30

1.6

1.5

61.74

62.89

ug/l

0.11

150

638

Venous complications and haemorrhoids in pregnancy

292

3.32

22.07

1.7

1.5

62.62

66.08

ug/l

0.35

292

Asthma/COPD (KELA code 203)

984

9085

0.72

21.88

1.5

58.80

60.24

ug/l

0.44

984

9085

Complications of surgical and medical care, not elsewhere classified

814

7734

0.70

21.68

1.5

56.87

60.68

ug/l

1.82

814

7734

Injuries to the shoulder and upper arm

485

5876

0.63

21.51

1.5

58.23

60.16

ug/l

0.48

485

5876

Disorders of eyelid, lacrimal system and orbit

562

6252

0.65

21.19

1.5

61.76

59.65

ug/l

0.48

562

6252

Disorders of gallbladder, biliary tract and pancreas

572

5399

0.66

21.12

1.5

51.50

60.25

ug/l

6.42

572

5399

Type 2 diabetes, strict (exclude DM1)

623

5404

0.67

20.96

1.6

1.5

46.05

60.76

ug/l

23.76

623

5404

Polycystic ovarian syndrome, broad definition

704

4881

1.51

20.95

1.5

57.12

60.59

ug/l

1.28

704

4881

Disorders of lipoprotein metabolism and other lipidaemias

1519

0.37

20.93

1.5

61.31

59.07

ug/l

0.17

1519

Type 2 diabetes, definitions combined

624

5404

0.67

20.83

1.6

1.5

46.01

60.78

ug/l

23.98

624

5404

Other disorders of urethra and urinary system

717

7200

0.69

20.80

1.5

60.63

60.30

ug/l

0.07

717

7200

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

764

7352

0.70

20.69

1.5

60.46

60.09

ug/l

0.08

764

7352

Bipolar affective disorders

183

3658

0.49

20.56

1.4

1.5

60.97

60.20

ug/l

0.08

183

3658

Phobic anxiety disorders

192

3739

0.50

20.36

1.4

1.5

58.15

60.62

ug/l

0.43

192

3739

Unspecified mental disorder

293

5082

0.57

20.13

1.4

1.5

55.56

60.55

ug/l

1.35

293

5082

Injuries to the head

1187

9339

0.75

19.84

1.5

58.27

60.28

ug/l

0.78

1187

9339

Leiomyoma of uterus

246

2535

0.54

19.79

1.4

59.54

59.24

ug/l

0.04

246

2535

Complications predominantly related to the puerperium

880

6362

1.41

19.77

1.6

1.5

59.86

60.04

ug/l

0.04

880

6362

Exposure to other specified factors

805

9638

0.71

19.51

1.5

53.94

60.55

ug/l

5.11

805

9638

Opioids

1322

8919

0.76

19.51

1.5

56.65

60.66

ug/l

2.86

1322

8919

Other disorders of ear

449

4547

0.63

19.47

1.5

56.03

60.11

ug/l

1.34

449

4547

Disorders of tooth development and eruption

410

2048

1.66

19.46

1.5

58.49

61.04

ug/l

0.64

410

2048

Obesity

1231

8789

1.33

19.45

1.5

42.73

62.39

ug/l

86.43

1231

8789

Other specific joint derangements/joint disorders

1020

8560

0.74

19.25

1.5

57.98

60.52

ug/l

1.15

1020

8560

Menorrhagia

455

3947

0.63

19.24

1.5

63.07

60.49

ug/l

0.52

455

3947

Obesity and other hyperalimentation

1231

8795

1.33

19.16

1.5

42.73

62.39

ug/l

86.45

1231

8795

Other (not insulin) diabetes medications

659

5604

0.69

19.13

1.6

1.5

47.06

61.05

ug/l

20.07

659

5604

Hyperkinetic disorders

312

5051

0.58

18.95

1.4

1.5

61.07

60.20

ug/l

0.13

312

5051

Other obstetric trauma

214

1116

2.01

18.90

1.6

1.5

61.17

60.19

ug/l

0.10

214

1116

Chronic apical periodontitis

1243

9130

0.76

18.90

1.5

56.73

60.53

ug/l

2.43

1243

9130

Mood disorders, excluding more controls

927

7436

0.73

18.89

1.4

1.5

59.27

60.33

ug/l

0.29

927

7436

Covid-19 confirmed case

500

3253

1.55

18.79

1.5

55.78

59.43

ug/l

1.17

500

3253

Renal tubulo-interstitial diseases

761

7817

0.71

18.77

1.5

61.82

59.94

ug/l

0.58

761

7817

Persistent mood disorders

2174

0.38

18.66

1.4

1.6

64.23

60.01

ug/l

0.32

2174

Kela-code for severe mental illness

215

3980

0.54

18.63

1.5

56.85

60.14

ug/l

0.54

215

3980

Disturbance of activity and attention

305

4941

0.58

18.55

1.4

1.5

61.16

60.38

ug/l

0.11

305

4941

Implicit Sepsis, including avohilmo

465

5099

0.65

18.53

1.5

58.35

59.94

ug/l

0.34

465

5099

183

3484

0.50

18.45

1.4

1.5

58.36

59.95

ug/l

0.21

183

3484

Exposure to unspecified factor

1046

9479

0.75

18.42

1.5

57.72

60.31

ug/l

1.23

1046

9479

Bleeding

247

3090

0.56

18.26

1.5

59.96

59.66

ug/l

0.04

247

3090

Dizziness and giddiness

445

5329

0.65

18.15

1.5

58.02

60.23

ug/l

0.56

445

5329

Social phobias

110

2492

0.43

18.04

1.4

1.6

60.30

60.26

ug/l

0.00

110

2492

Acute upper respiratory infections

1590

7479

1.28

18.01

1.5

58.77

60.80

ug/l

1.07

1590

7479

Hard cardiovascular diseases

1259

0.37

17.96

1.4

1.5

55.52

60.31

ug/l

0.46

1259

Lower back pain or/and sciatica

1147

9345

0.76

17.79

1.5

56.52

60.51

ug/l

2.55

1147

9345

Psychiatric diseases

947

6410

0.74

17.71

1.5

1.6

58.76

60.33

ug/l

0.54

947

6410

Failed induction of labour

319

1928

1.74

17.51

1.5

56.21

60.04

ug/l

0.85

319

1928

Care involving use of rehabilitation procedures

308

4580

0.60

17.39

1.4

1.5

60.16

60.22

ug/l

0.01

308

4580

Outcome of delivery

164

467

2.18

17.31

1.4

55.11

60.98

ug/l

0.81

164

467

Low back pain

912

8283

0.74

17.26

1.5

56.25

60.72

ug/l

2.69

912

8283

Schizophrenia or delusion

177

3388

0.52

17.19

1.5

51.28

59.88

ug/l

2.27

177

3388

Schizophrenia, schizotypal and delusional disorders

177

3387

0.52

17.17

1.5

51.28

59.89

ug/l

2.28

177

3387

Insomnia

1552

8532

1.27

17.14

1.4

1.5

59.61

60.27

ug/l

0.24

1552

8532

Nonorganic sleeping disorders, excluding more controls

241

4173

0.57

16.80

1.5

61.26

60.47

ug/l

0.10

241

4173

Anaemias

450

4343

0.65

16.78

1.6

1.5

62.54

61.03

ug/l

0.29

450

4343

Endometriosis diagnosis and infertility diagnosis occurring together

337

2077

1.67

16.65

1.4

1.5

60.92

59.62

ug/l

0.24

337

2077

Abnormalities of forces of labour

195

1023

1.95

16.54

1.5

1.4

59.37

59.25

ug/l

0.01

195

1023

Other reaction to severe stress, and adjustment disorders

523

7576

0.68

16.34

1.5

57.10

60.33

ug/l

1.03

523

7576

Type 2 diabetes, wide definition

124

1673

0.47

16.22

1.4

1.5

53.89

60.56

ug/l

0.84

124

1673

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

635

7697

0.70

16.02

1.5

60.31

59.99

ug/l

0.06

635

7697

Bronchitis

1761

8529

1.24

15.72

1.5

56.98

60.84

ug/l

3.39

1761

8529

Disorders of psychological development

174

2970

0.53

15.35

1.5

1.6

59.26

59.97

ug/l

0.08

174

2970

Bacterial infection, other or unspecified, including avohilmo

172

2639

0.53

15.32

1.5

54.87

59.51

ug/l

1.01

172

2639

Panic disorder

260

4290

0.59

15.31

1.4

1.5

58.38

60.67

ug/l

0.44

260

4290

Other sexually transmitted chlamydial diseases, including avohilmo

243

4045

0.58

15.18

1.5

57.76

60.26

ug/l

0.44

243

4045

Injuries to the knee and lower leg

1346

9180

0.79

15.18

1.5

56.59

60.56

ug/l

2.73

1346

9180

Heart failure, not strict

1021

0.33

15.07

1.5

77.79

60.93

ug/l

1.02

1021

Ectopic pregnancy

340

2146

1.61

15.02

1.5

1.4

56.82

61.87

ug/l

1.58

340

2146

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

476

4404

0.68

14.85

1.5

58.05

59.16

ug/l

0.25

476

4404

Other heart diseases

365

3648

0.65

14.75

1.5

61.32

59.97

ug/l

0.24

365

3648

Habitual aborter

138

684

2.19

14.70

1.8

1.5

48.02

60.23

ug/l

3.92

138

684

Intrahepatic Cholestasis of Pregnancy (ICP)

288

1772

1.69

14.63

1.6

1.5

61.70

60.08

ug/l

0.25

288

1772

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

288

1772

1.68

14.48

1.6

1.5

61.70

60.08

ug/l

0.25

288

1772

Other soft tissue disorders, not elsewhere classified

1180

8534

0.78

14.39

1.5

58.49

60.38

ug/l

0.73

1180

8534

Cardiac arrhythmias

640

5662

0.72

14.36

1.5

60.16

61.39

ug/l

0.32

640

5662

Other and unspecified mood [affective] disorders

1892

0.42

14.18

1.6

53.59

60.28

ug/l

0.98

1892

Pure hypercholesterolaemia

1168

0.41

14.09

1.6

1.5

54.43

59.84

ug/l

0.69

1168

Selective serotonin reuptake inhibitors

1106

7357

0.78

14.00

1.5

1.6

58.42

60.39

ug/l

0.80

1106

7357

344

4585

0.65

13.99

1.4

1.5

59.02

60.34

ug/l

0.21

344

4585

Malignant neoplasm of breast, including Hilmo

1040

0.37

13.92

1.2

1.5

67.98

59.24

ug/l

0.77

1040

Malaise and fatigue

316

3879

0.64

13.86

1.5

58.65

60.54

ug/l

0.34

316

3879

Complications associated with artificial fertilization

122

593

2.25

13.78

1.3

1.5

61.58

59.10

ug/l

0.26

122

593

Malignant neoplasm of breast, HER2-negative, including Hilmo

1044

0.38

13.76

1.2

1.5

67.22

59.14

ug/l

0.70

1044

Sleep disorders

1490

8294

1.24

13.60

1.4

1.5

59.42

60.19

ug/l

0.29

1490

8294

Other sexually transmitted chlamydial diseases

108

2204

0.47

13.60

1.6

1.5

55.88

60.20

ug/l

0.54

108

2204

Other predominantly sexually transmitted diseases, not elsewhere classified

234

3850

0.60

13.57

1.5

63.07

59.72

ug/l

0.55

234

3850

Other medical care

135

2196

0.51

13.56

1.4

1.5

60.64

59.48

ug/l

0.11

135

2196

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

398

2.48

13.48

1.6

1.5

56.16

58.60

ug/l

0.21

398

Depression medications

667

4555

0.73

13.43

1.5

57.72

60.80

ug/l

1.21

667

4555

Other and unspecified nonorganic psychotic disorders

145

2718

0.53

13.40

1.4

1.5

49.92

59.74

ug/l

2.42

145

2718

159

860

2.01

13.32

1.6

1.5

60.88

60.05

ug/l

0.07

159

860

Suicide or other Intentional self-harm

197

3381

0.58

13.29

1.4

1.5

55.75

60.06

ug/l

0.72

197

3381

Any event in hilmo or specialist outpatient

+∞

13.26

1.5

0.0

55.29

—

ug/l

—

Spondylopathies

270

2562

0.62

13.11

1.5

51.53

59.42

ug/l

3.43

270

2562

Dyspnoea

667

6498

0.74

13.08

1.5

57.47

60.45

ug/l

1.27

667

6498

Concussion

638

6701

0.73

13.02

1.5

56.01

60.87

ug/l

2.47

638

6701

Ovarian hyperstimulation (induction)

115

561

2.25

12.93

1.3

1.5

60.89

60.42

ug/l

0.04

115

561

Biguanides

642

5262

0.73

12.84

1.6

1.5

46.89

60.78

ug/l

19.23

642

5262

Malignant neoplasm of breast

961

0.37

12.82

1.2

1.5

67.21

59.35

ug/l

0.63

961

Artificial joint operation, meniscal resection

178

2011

0.56

12.78

1.4

1.5

52.86

58.92

ug/l

1.44

178

2011

Disorders of lens

632

0.25

12.62

1.5

64.77

61.23

ug/l

0.11

632

KRA_PSY_EATING, excluding more controls

276

4203

0.63

12.58

1.6

63.82

60.56

ug/l

0.52

276

4203

Any reimbursement code in KELA

1208

7561

0.79

12.58

1.5

58.65

60.48

ug/l

0.68

1208

7561

Symptoms and signs involving the urinary system

340

3849

0.66

12.40

1.5

60.28

59.95

ug/l

0.05

340

3849

Malignant neoplasm of breast, HER2-negative

952

0.38

12.29

1.2

1.5

66.40

59.28

ug/l

0.56

952

Schizophrenia

1064

0.29

12.22

1.5

53.27

60.00

ug/l

0.27

1064

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

401

5738

0.69

12.02

1.5

58.07

60.35

ug/l

0.55

401

5738

Spirochaetal infections, other/unspecified, including avohilmo

1907

0.47

11.98

1.4

1.5

59.50

59.65

ug/l

0.01

1907

Maternal care for known or suspected disproportion

226

2.76

11.95

1.4

1.3

58.87

58.43

ug/l

0.02

226

Acne, including avohilmo

791

8247

0.76

11.91

1.4

1.6

63.44

60.02

ug/l

1.25

791

8247

Fitting and adjustment of other devices

773

0.23

11.90

1.3

1.5

59.89

61.06

ug/l

0.03

773

Inflammatory disease of uterus

466

3312

1.44

11.87

1.6

1.5

57.21

59.90

ug/l

0.68

466

3312

Lyme disease, including avohilmo

1872

0.47

11.85

1.4

1.5

58.50

59.78

ug/l

0.10

1872

Lyme disease

1872

0.47

11.85

1.4

1.5

58.50

59.78

ug/l

0.10

1872

Placental disorders

144

3.40

11.80

1.7

1.4

70.94

60.05

ug/l

0.79

144

Erysipelas, including avohilmo

209

2550

0.61

11.62

1.5

56.55

59.77

ug/l

0.50

209

2550

Gonarthrosis

954

0.44

11.61

1.4

1.5

49.21

60.33

ug/l

2.09

954

Polyp of the female genital tract

220

2031

0.61

11.61

1.4

1.5

60.32

60.09

ug/l

0.02

220

2031

Gender identity disorders

459

0.14

11.60

1.0

1.6

51.43

58.83

ug/l

—

459

Asthma, unspecified (mode), excluding more controls

457

4587

0.71

11.56

1.5

59.57

62.11

ug/l

0.53

457

4587

Alcohol use disorder, Swedish definition

241

3464

0.63

11.48

1.5

57.42

59.50

ug/l

0.33

241

3464

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

548

7310

0.73

11.45

1.5

57.65

60.58

ug/l

0.91

548

7310

Inflammatory disorders of breast

279

1813

1.60

11.43

1.6

1.5

61.16

59.44

ug/l

0.29

279

1813

Conjunctivitis (acute, non atopic), including avohilmo

1488

7385

1.22

11.40

1.5

59.13

59.85

ug/l

0.26

1488

7385

Hypothyroidism, drug reimbursement

147

1832

0.55

11.38

1.5

60.67

60.15

ug/l

0.05

147

1832

Speech and linguistic disorders, excluding more controls

126

2175

0.53

11.33

1.6

58.52

61.33

ug/l

0.32

126

2175

Implicit Sepsis

380

4037

0.69

11.26

1.5

58.05

60.42

ug/l

0.52

380

4037

Other spirochaetal diseases

1917

0.49

11.25

1.5

57.99

59.71

ug/l

0.14

1917

Cholelithiasis, broad definition with cholecystitis

526

4785

0.73

11.19

1.5

50.83

59.97

ug/l

6.55

526

4785

Any death

534

0.20

11.19

1.2

1.5

72.43

58.12

ug/l

0.43

534

Poisoning by medicine

227

3595

0.62

11.16

1.4

1.5

55.79

60.07

ug/l

0.78

227

3595

328

4315

0.68

11.10

1.4

1.5

58.41

60.17

ug/l

0.29

328

4315

Polycystic ovarian syndrome, consortium definition

1314

9184

0.81

11.10

1.5

60.18

60.07

ug/l

0.03

1314

9184

Asthma, unspecified (mode)

457

4592

0.71

11.07

1.5

59.57

62.09

ug/l

0.53

457

4592

Migraine, single triptan purchase ok & required. ICD-code if available is included

1454

8123

1.22

11.07

1.5

58.57

60.40

ug/l

0.86

1454

8123

Triptan medication for migraine, single purchase ok

1454

8123

1.22

11.07

1.5

58.57

60.40

ug/l

0.86

1454

8123

Other spirochaetal diseases, including avohilmo

1973

0.50

11.07

1.4

1.5

59.99

59.60

ug/l

0.03

1973

Cerebrovascular diseases

1090

0.44

10.96

1.4

1.5

54.16

60.88

ug/l

0.87

1090

Substance abuse

384

5080

0.70

10.84

1.4

1.5

56.84

60.60

ug/l

0.99

384

5080

ILD medications: immunosuppressive drugs

535

6539

0.74

10.82

1.5

61.91

60.29

ug/l

0.33

535

6539

Gonarthrosis [arthrosis of knee](FG)

942

0.45

10.75

1.4

1.5

49.21

60.82

ug/l

2.23

942

Uterine polyps

161

1624

0.57

10.74

1.4

1.5

60.51

59.65

ug/l

0.07

161

1624

Nonorganic sleeping disorders

241

3727

0.64

10.66

1.5

61.26

60.01

ug/l

0.17

241

3727

Poisoning by drugs, medicaments and biological substances

253

3874

0.65

10.66

1.4

1.5

55.36

60.22

ug/l

1.05

253

3874

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

324

3004

0.68

10.63

1.5

57.58

59.30

ug/l

0.37

324

3004

Dislocation, sprain and strain of joints and ligaments of knee

693

8117

0.77

10.50

1.5

55.67

60.71

ug/l

2.34

693

8117

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

169

2824

0.59

10.49

1.4

1.5

56.32

59.64

ug/l

0.45

169

2824

Other puerperal infections

416

2985

1.44

10.48

1.6

1.5

61.01

59.22

ug/l

0.36

416

2985

Mental and behavioural disorders due to psychoactive substance use

415

5299

0.71

10.36

1.4

1.5

58.16

60.48

ug/l

0.50

415

5299

Chronic lower respiratory diseases

1436

9086

0.83

10.24

1.5

58.93

60.24

ug/l

0.52

1436

9086

Behavioural syndromes associated with physiological disturbances and physical factors

1474

8296

1.21

10.24

1.4

1.5

59.47

60.19

ug/l

0.25

1474

8296

Bacterial infection, other or unspecified

133

2001

0.56

10.23

1.5

53.83

59.39

ug/l

1.13

133

2001

Other arthrosis

853

0.40

10.20

1.3

1.5

54.96

61.30

ug/l

0.46

853

Headache

1230

7803

1.22

10.03

1.5

59.31

60.50

ug/l

0.44

1230

7803

Disorders of thyroid, IBD co-morbidities

293

2956

0.67

10.03

1.5

62.76

62.22

ug/l

0.07

293

2956

Lumbar disc prolapse

403

4167

0.71

9.98

1.5

58.23

60.56

ug/l

0.47

403

4167

Diseases of middle ear and mastoid

1331

9027

1.21

9.82

1.5

58.22

60.40

ug/l

1.04

1331

9027

Injuries to the elbow and forearm

721

7902

0.78

9.81

1.5

58.97

60.07

ug/l

0.27

721

7902

Schizoaffective disorder

849

0.30

9.56

1.2

1.5

51.40

60.46

ug/l

0.94

849

Fenamates

137

1603

0.57

9.28

1.4

1.5

68.15

65.23

ug/l

0.27

137

1603

Intestinal infectious diseases

1453

9072

1.19

9.27

1.5

60.51

59.98

ug/l

0.18

1453

9072

Wide developmental disorders, excluding more controls

890

0.34

9.27

1.4

1.6

58.73

60.31

ug/l

0.09

890

Disorders of choroid and retina

229

2453

0.65

9.26

1.5

65.35

59.14

ug/l

1.00

229

2453

Major coronary heart disease event

721

0.41

9.17

1.4

1.5

61.43

60.35

ug/l

0.05

721

Diseases of arteries, arterioles and capillaries

1310

0.52

9.17

1.4

1.5

60.41

60.60

ug/l

0.01

1310

Presence of other functional implants

619

0.33

9.13

1.4

1.5

98.43

60.33

ug/l

1.11

619

Vasomotor and allergic rhinitis

515

6627

0.75

9.02

1.5

61.09

60.71

ug/l

0.07

515

6627

Hernia

535

4688

0.76

9.01

1.5

63.97

59.87

ug/l

1.05

535

4688

Other degenerative diseases of the nervous system

1157

0.50

9.00

1.4

1.5

54.16

61.20

ug/l

0.87

1157

Acetic acid derivatives and related substances

315

2336

0.69

8.97

1.4

1.6

57.80

64.34

ug/l

2.05

315

2336

Urinary track infection

1207

7279

0.82

8.96

1.5

59.59

60.28

ug/l

0.22

1207

7279

Agoraphobia

851

0.33

8.95

1.6

57.43

58.74

ug/l

0.07

851

Other surgical follow-up care

462

2.03

8.85

1.6

53.74

59.82

ug/l

0.67

462

Oxicams

124

1234

0.57

8.82

1.4

1.5

56.44

65.22

ug/l

1.60

124

1234

Infections of breast associated with childbirth

175

1092

1.68

8.76

1.6

1.5

61.30

59.44

ug/l

0.23

175

1092

Infections, IBD-co-morbidities

1096

0.50

8.59

1.5

53.71

62.68

ug/l

1.54

1096

Cholelithiasis

518

4643

0.76

8.53

1.5

50.90

60.04

ug/l

6.39

518

4643

Mixed and other personality disorders

1082

0.42

8.41

1.2

1.5

67.15

60.25

ug/l

0.36

1082

Persons encountering health services for examination and investigation

790

4949

0.80

8.35

1.6

1.5

58.61

61.03

ug/l

0.86

790

4949

Emergency coronary revascularization (for ACS)

664

0.42

8.33

1.4

1.5

61.56

59.46

ug/l

0.10

664

Rotator cuff syndrome

122

1449

0.58

8.28

1.4

1.5

53.83

59.96

ug/l

0.98

122

1449

Senile cataract

223

0.16

8.24

1.8

1.6

104.25

57.21

ug/l

—

223

Coronary revascularization (ANGIO or CABG)

664

0.42

8.21

1.4

1.5

61.56

59.37

ug/l

0.11

664

Allergic rhinitis

473

6132

0.75

8.21

1.5

61.54

60.27

ug/l

0.28

473

6132

Percutaneous Coronary Intervention

664

0.42

8.19

1.4

1.5

61.56

59.37

ug/l

0.11

664

Anxiety disorders, excluding more controls

956

7436

0.82

8.19

1.5

58.73

60.33

ug/l

0.52

956

7436

Other cataract

470

0.25

8.13

1.6

1.5

75.65

59.09

ug/l

0.43

470

Liveborn infants according to place of birth

7.11

8.08

1.7

1.3

64.26

43.90

ug/l

1.29

Cerebrovascular diseases (FINNGEN)

883

0.47

8.05

1.4

1.5

50.44

61.68

ug/l

2.18

883

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

148

903

1.67

7.79

1.5

63.78

60.79

ug/l

0.31

148

903

Puerperal sepsis

155

957

1.64

7.73

1.8

1.5

53.39

59.11

ug/l

1.25

155

957

Conductive and sensorineural hearing loss

215

2127

0.67

7.69

1.5

50.95

59.66

ug/l

3.22

215

2127

Meniscus derangement

129

1424

0.60

7.62

1.6

1.5

52.22

60.36

ug/l

1.51

129

1424

Asthma (diagnoses ohter than nonallergic)

971

9417

0.83

7.42

1.5

58.24

60.28

ug/l

0.73

971

9417

Mood disorders

1169

8849

0.84

7.41

1.4

1.5

59.84

60.14

ug/l

0.08

1169

8849

Sensorineural hearing loss

150

1594

0.63

7.41

1.5

50.87

60.28

ug/l

2.51

150

1594

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

727

8582

0.81

7.41

1.5

62.65

60.26

ug/l

0.79

727

8582

Autoimmune diseases related-to ILD

879

8890

0.82

7.38

1.5

55.34

60.64

ug/l

3.72

879

8890

Infections with a predominantly sexual mode of transmission, including avohilmo

871

9627

0.82

7.36

1.5

59.20

60.16

ug/l

0.29

871

9627

Continuous positive airway pressure

280

0.18

7.35

1.7

1.5

51.22

62.42

ug/l

—

280

Mood [affective] disorders

1168

8849

0.84

7.34

1.4

1.5

59.87

60.14

ug/l

0.07

1168

8849

Endometriosis

695

5015

0.80

7.33

1.4

1.5

60.93

60.15

ug/l

0.19

695

5015

Hydatidiform mole

193

2.51

7.32

1.8

1.4

76.38

56.90

ug/l

0.48

193

Allergic conjunctivitis

762

8978

0.81

7.30

1.5

62.51

60.16

ug/l

0.80

762

8978

Dermatitis and eczema

1631

8336

1.16

7.29

1.5

62.58

59.56

ug/l

1.65

1631

8336

Ovarian cyst

774

5424

0.81

7.22

1.5

60.81

60.09

ug/l

0.17

774

5424

Gastro-oesophageal reflux disease

362

4087

0.74

7.07

1.5

54.93

59.73

ug/l

1.58

362

4087

Speech and linguistic disorders

126

1948

0.61

7.03

1.6

58.52

59.83

ug/l

0.13

126

1948

Pollen allergy

340

4496

0.74

7.03

1.5

60.81

60.46

ug/l

0.06

340

4496

Ischemic heart diseases

968

0.56

6.85

1.5

57.19

61.07

ug/l

0.41

968

Wide developmental disorders

788

0.39

6.84

1.4

1.6

58.73

59.53

ug/l

0.04

788

Other inflammation of eyelid, including avohilmo

632

7832

0.80

6.84

1.5

60.02

59.95

ug/l

0.01

632

7832

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1443

7966

1.16

6.83

1.5

59.49

60.32

ug/l

0.30

1443

7966

STROKE

1115

0.57

6.80

1.4

1.5

55.05

60.74

ug/l

0.78

1115

Other specified and unspecified personality disorders

1315

0.53

6.64

1.5

58.85

60.75

ug/l

0.15

1315

Mental and behavioural disorders due to alcohol

304

3930

0.73

6.63

1.4

1.5

58.98

60.27

ug/l

0.19

304

3930

Other disorders of breast and lactation associated with childbirth

706

0.37

6.59

1.4

1.5

55.91

59.75

ug/l

0.21

706

Eating disorder

276

3747

0.72

6.59

1.6

1.5

63.82

60.23

ug/l

0.59

276

3747

Autism spe, excluding more controls

715

0.38

6.57

1.4

1.6

61.16

58.93

ug/l

0.12

715

Eating disorders

279

3789

0.72

6.56

1.6

1.5

64.88

60.28

ug/l

0.80

279

3789

Family history of other conditions

291

2.13

6.44

1.6

1.5

65.46

58.51

ug/l

0.53

291

Coxibs

337

2368

0.74

6.42

1.5

1.6

53.39

64.35

ug/l

5.31

337

2368

Obsessive-compulsive disorder

150

2254

0.65

6.23

1.5

1.6

58.84

60.42

ug/l

0.18

150

2254

Oxycodone

782

0.46

6.23

1.3

1.5

49.97

62.32

ug/l

1.47

782

Organic, including symptomatic, mental disorders

441

0.35

6.14

1.5

1.6

61.89

59.56

ug/l

0.06

441

Liquid cancers, including Hilmo

849

0.48

6.14

1.6

1.5

59.00

59.50

ug/l

0.03

849

Unspecified maternal hypertension

279

2.14

6.06

1.5

48.16

59.81

ug/l

1.68

279

Other abnormal uterine and vaginal bleeding

219

2217

0.70

6.02

1.5

62.30

60.23

ug/l

0.20

219

2217

Gonarthrosis,primary

630

0.50

5.99

1.3

1.5

50.04

60.14

ug/l

1.26

630

Dental operations

419

1654

1.31

5.88

1.5

58.84

59.94

ug/l

0.20

419

1654

Certain infectious and parasitic diseases, including avohilmo

860

5139

0.84

5.86

1.5

57.73

60.99

ug/l

1.60

860

5139

Stroke, excluding SAH

535

0.42

5.83

1.3

1.5

45.28

59.22

ug/l

1.79

535

Acute tubulo-interstitial nephritis

627

6456

0.82

5.81

1.5

60.32

60.08

ug/l

0.05

627

6456

Other neurological diseases

277

2901

0.74

5.80

1.5

60.50

59.19

ug/l

0.23

277

2901

Other retinal disorders

173

1921

0.68

5.80

1.5

66.00

59.16

ug/l

0.96

173

1921

Use of disulfiram, acamprosate or naltrexone

284

0.21

5.78

1.3

1.5

71.51

56.60

ug/l

—

284

Malignant neoplasm of breast, ER-positive, including Hilmo

505

0.40

5.76

1.2

1.5

53.63

59.60

ug/l

0.45

505

Open wound of head

248

3183

0.73

5.71

1.5

60.82

60.25

ug/l

0.05

248

3183

Medical abortion

1373

6465

1.16

5.69

1.5

57.65

61.64

ug/l

2.77

1373

6465

Disorders of skin appendages

688

8238

0.83

5.66

1.4

1.5

60.76

60.10

ug/l

0.13

688

8238

Malignant neoplasm of breast, HER-positive

498

0.40

5.57

1.2

1.5

53.63

59.48

ug/l

0.44

498

Complications of procedures, not elsewhere classified

707

6842

0.83

5.56

1.5

56.73

60.56

ug/l

1.68

707

6842

Falls/tendency to fall

1480

8442

0.88

5.52

1.5

58.71

60.42

ug/l

0.75

1480

8442

Ischaemic Stroke, excluding all haemorrhages

468

0.39

5.49

1.3

1.5

47.12

59.10

ug/l

1.10

468

All dysplastic lesions of the cervix uteri, vagina or vulva

625

7359

0.82

5.43

1.5

59.45

60.20

ug/l

0.16

625

7359

Fever of other and unknown origin

539

5739

0.81

5.42

1.5

58.15

60.46

ug/l

0.67

539

5739

Osteopathies and chondropathies

294

3551

0.75

5.41

1.4

1.5

61.28

59.55

ug/l

0.26

294

3551

Autism

671

0.42

5.40

1.4

1.6

59.55

59.48

ug/l

0.00

671

Insulin, fast-acting (human)

100

1599

0.62

5.38

1.4

1.5

72.98

60.39

ug/l

1.44

100

1599

Acute and transient psychotic disorders

899

0.50

5.38

1.6

1.5

49.26

61.14

ug/l

1.23

899

Stroke, including SAH

622

0.48

5.36

1.4

1.5

50.98

60.58

ug/l

1.11

622

Mental and behavioural disorders due to alcohol, excluding acute intoxication

199

2755

0.71

5.31

1.5

56.63

59.45

ug/l

0.43

199

2755

Disorder of the sleep-wake schedule

266

0.22

5.31

1.5

1.6

36.44

57.42

ug/l

—

266

Accidents

1116

6471

0.86

5.29

1.5

56.89

61.29

ug/l

2.89

1116

6471

All dysplastic lesions of the cervix uteri

609

7224

0.82

5.25

1.5

58.92

60.24

ug/l

0.32

609

7224

Open wound of wrist and hand

441

5324

0.80

5.25

1.4

1.5

54.31

60.83

ug/l

3.22

441

5324

Alcohol abuse, main dg, excluding more controls

100

1588

0.62

5.23

1.4

1.6

57.28

61.49

ug/l

0.44

100

1588

Mental disorders, not otherwise specified

1457

0.61

5.21

1.4

1.5

51.38

60.03

ug/l

1.85

1457

Certain infectious and parasitic diseases

1304

7465

0.87

5.17

1.5

59.28

60.45

ug/l

0.44

1304

7465

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

669

7892

0.83

5.17

1.5

54.88

60.42

ug/l

3.11

669

7892

LSIL lesion of the cervix uteri, vagina or vulva

218

2969

0.73

5.14

1.5

59.97

59.66

ug/l

0.04

218

2969

Dissociative [conversion] disorders

1051

0.55

5.08

1.4

1.6

62.10

59.48

ug/l

0.15

1051

Pain and other conditions associated with female genital organs and menstrual cycle

571

5769

0.82

5.07

1.4

1.5

58.67

60.10

ug/l

0.36

571

5769

Autism spe

638

0.43

5.04

1.4

1.6

61.16

58.40

ug/l

0.15

638

Dipeptidyl peptidase 4 (DPP-4) inhibitors

421

0.37

5.01

1.4

1.5

47.42

58.34

ug/l

0.77

421

Disorders of the thyroid gland

1532

8800

1.13

4.97

1.5

59.21

60.26

ug/l

0.37

1532

8800

Diabetic nephropathy, excluding more controls

504

0.42

4.96

1.4

1.6

91.59

48.52

ug/l

1.84

504

Dental caries

138

1914

0.68

4.96

1.5

52.80

60.63

ug/l

1.46

138

1914

Malignant neoplasm of skin, including Hilmo

582

0.51

4.94

1.5

50.02

59.23

ug/l

1.13

582

Migraine without aura

449

5540

0.80

4.93

1.5

61.85

60.07

ug/l

0.32

449

5540

Other disorders of binocular vision

258

2.04

4.92

1.5

57.49

56.85

ug/l

0.03

258

Other anxiety disorders

875

8671

0.85

4.92

1.4

1.5

59.05

60.30

ug/l

0.39

875

8671

Complications specific to multiple gestation

3.54

4.90

1.6

1.3

75.38

61.02

ug/l

0.44

Injuries to the hip and thigh

196

2428

0.72

4.90

1.5

60.61

59.89

ug/l

0.07

196

2428

Nephropathy related operations

308

0.29

4.87

1.3

1.5

112.40

57.01

ug/l

—

308

Caries of dentine

114

1670

0.65

4.86

1.5

53.30

60.20

ug/l

1.07

114

1670

Alcohol use disorder, ICD-based

187

2595

0.72

4.84

1.4

1.5

56.14

59.30

ug/l

0.50

187

2595

Acne

298

3816

0.76

4.84

1.4

1.6

63.49

59.44

ug/l

0.77

298

3816

Other external causes of accidental injury

1125

6471

0.87

4.81

1.5

57.20

61.29

ug/l

2.53

1125

6471

Migraine without aura and triptan purchases

363

4570

0.79

4.81

1.4

1.5

61.81

60.70

ug/l

0.15

363

4570

Liquid cancers

744

0.49

4.78

1.7

1.5

60.68

59.80

ug/l

0.05

744

LSIL lesion of the cervix uteri

206

2792

0.73

4.78

1.5

58.79

59.51

ug/l

0.09

206

2792

Unspecified privation

796

0.50

4.78

1.5

54.30

59.89

ug/l

0.32

796

Follow-up examination after treatment for conditions other than malignant neoplasms

612

4890

0.83

4.77

1.6

1.5

57.82

61.07

ug/l

1.21

612

4890

External causes of morbidity and mortality

1008

5838

0.86

4.75

1.5

57.55

61.52

ug/l

2.11

1008

5838

Benign neoplasms

1456

8928

0.88

4.73

1.5

59.36

60.11

ug/l

0.26

1456

8928

Chronic rhinitis, nasopharyngitis and pharyngitis

266

3484

0.76

4.72

1.5

59.70

60.24

ug/l

0.08

266

3484

Injury, poisoning and certain other consequences of external causes

868

5074

0.85

4.64

1.5

56.91

61.37

ug/l

2.43

868

5074

Post-traumatic stress disorder

240

3157

0.75

4.63

1.5

1.6

53.84

60.42

ug/l

1.47

240

3157

Desensitization to allergens

1176

0.59

4.62

1.5

1.6

56.84

59.50

ug/l

0.24

1176

Chronic laryngitis and laryngotracheitis

597

0.43

4.61

1.5

54.07

60.49

ug/l

0.37

597

Other disorders of eye and adnexa

106

1608

0.65

4.56

1.5

68.54

59.71

ug/l

1.03

106

1608

Infections of the skin and subcutaneous tissue

586

6893

0.83

4.55

1.5

55.93

60.45

ug/l

2.04

586

6893

Complications of the puerperium, not elsewhere classified

159

1127

1.45

4.52

1.6

1.5

66.05

60.51

ug/l

0.74

159

1127

Bulimia nervosa (incl. atypical)

1437

0.63

4.51

1.6

55.39

59.19

ug/l

0.52

1437

Personal history of malignant neoplasm

372

0.29

4.50

2.0

1.5

62.86

57.86

ug/l

0.24

372

Intentional self-harm by sharp object

622

0.45

4.50

1.2

1.6

44.01

58.17

ug/l

1.23

622

Missing teeth due to accident, extraction or parodontitis

164

2050

0.71

4.48

1.4

1.5

64.28

59.07

ug/l

0.52

164

2050

Lack of expected normal physiological development

519

0.44

4.46

1.3

1.6

56.26

58.41

ug/l

0.09

519

Epilepsy

186

2536

0.73

4.46

1.4

1.5

58.84

59.62

ug/l

0.09

186

2536

Mental retardation, excluding more controls

398

0.33

4.45

1.4

1.6

40.56

58.83

ug/l

1.00

398

Episodal and paroxysmal disorders

1509

8575

0.89

4.42

1.5

60.02

60.19

ug/l

0.05

1509

8575

Inguinal hernia

195

1768

0.73

4.42

1.5

63.64

59.96

ug/l

0.59

195

1768

Dysplasia of cervi uteri

581

4873

0.83

4.42

1.5

59.40

60.16

ug/l

0.16

581

4873

Diastasis of muscle

145

2.32

4.42

1.5

1.6

70.08

54.90

ug/l

0.60

145

Alcohol dependence

881

0.54

4.41

1.4

1.5

52.47

60.00

ug/l

0.82

881

Type1 diabetes, definitions combined, early onset

1352

0.63

4.39

1.5

1.6

67.63

59.93

ug/l

0.85

1352

Erysipelas

117

1495

0.67

4.39

1.5

57.00

59.84

ug/l

0.27

117

1495

Vocal cord dysfunction

1171

0.63

4.38

1.6

1.5

63.56

62.91

ug/l

0.05

1171

Motor disorders, excluding more controls

269

0.30

4.36

1.4

1.6

81.34

58.45

ug/l

—

269

Depression or dysthymia

626

4069

0.84

4.36

1.5

1.6

59.02

59.98

ug/l

0.21

626

4069

Provisional assignment of new diseases of uncertain etiology

819

6989

1.17

4.35

1.5

56.59

60.27

ug/l

1.74

819

6989

Type 1 diabetes, strict definition

1438

0.64

4.35

1.5

70.97

60.91

ug/l

1.35

1438

Coxarthrosis

361

0.43

4.32

1.4

1.5

74.99

60.01

ug/l

0.28

361

Heterophoria

174

1258

1.40

4.30

1.5

1.6

64.32

59.55

ug/l

0.52

174

1258

Codes for special purposes

819

6997

1.16

4.29

1.5

56.59

60.26

ug/l

1.73

819

6997

Convergence insufficiency and excess

308

1.87

4.29

1.7

1.6

57.08

56.55

ug/l

0.03

308

Caries of enamel

1364

7928

1.13

4.27

1.5

62.34

59.55

ug/l

1.51

1364

7928

Specific development disorders of scholastic skills

1099

0.60

4.23

1.5

1.6

58.12

59.59

ug/l

0.10

1099

Second line medication for Crohn's disease

443

5390

0.82

4.22

1.5

61.05

60.08

ug/l

0.18

443

5390

Crushed, pushed or stepped on by crowd or human stampede

1189

0.61

4.22

1.4

1.6

51.98

60.14

ug/l

1.35

1189

Disorders of synovium and tendon

525

5341

0.83

4.22

1.5

56.97

60.33

ug/l

1.11

525

5341

Renal failure

686

0.53

4.21

1.4

1.5

89.37

60.27

ug/l

2.27

686

Umbilical hernia

216

1617

1.34

4.19

1.6

1.5

62.50

59.16

ug/l

0.45

216

1617

Other eating disorders

155

2129

0.71

4.17

1.6

70.63

59.62

ug/l

1.57

155

2129

Embedded and impacted teeth

1136

8156

1.14

4.16

1.5

61.47

59.88

ug/l

0.56

1136

8156

L04AA Selective immunosuppressants

106

1578

0.67

4.16

1.5

68.67

59.62

ug/l

0.89

106

1578

Symptoms and signs involving the digestive system and abdomen

1368

6090

1.13

4.14

1.5

58.85

60.40

ug/l

0.62

1368

6090

Diseases of the eye and adnexa

1353

7609

0.89

4.13

1.5

61.56

59.63

ug/l

0.74

1353

7609

Type 1 diabetes, strict definition, subgroup 1

1419

0.65

4.11

1.5

70.97

60.98

ug/l

1.34

1419

L04AX Other immunosuppressants

403

4934

0.81

4.08

1.5

61.50

59.95

ug/l

0.29

403

4934

Diseases of arteries, arterioles and capillaries (FINNGEN)

276

0.35

4.07

1.6

1.5

51.40

56.93

ug/l

0.22

276

Aplastic and other anaemias

108

1462

0.67

4.07

1.6

1.5

66.87

59.45

ug/l

0.94

108

1462

Implicit bacterial Sepsis, including avohilmo

1139

0.65

4.04

1.4

1.5

57.30

60.27

ug/l

0.37

1139

Endocrine, nutritional and metabolic diseases

1568

7105

1.12

4.01

1.6

1.5

55.62

62.46

ug/l

7.61

1568

7105

Depression

1175

8849

0.88

3.99

1.4

1.5

58.87

60.14

ug/l

0.44

1175

8849

Disorders of conjunctiva

1078

9445

0.88

3.98

1.5

61.22

59.93

ug/l

0.45

1078

9445

Hernia of abdominal wall

283

2216

1.28

3.96

1.6

1.5

63.74

59.88

ug/l

0.55

283

2216

Sub-endpoint used in defining T1D endpoints

203

2642

0.75

3.94

1.5

67.61

59.48

ug/l

1.48

203

2642

Abdominal and pelvic pain

1361

6090

1.12

3.93

1.5

58.49

60.40

ug/l

0.84

1361

6090

Pneumococcal septicemia

213

1.95

3.90

1.7

1.6

49.44

55.59

ug/l

0.46

213

Other diseases of upper respiratory tract

1270

7423

0.89

3.89

1.5

58.96

60.70

ug/l

0.72

1270

7423

Dyshidrosis [pompholyx]

220

0.27

3.84

1.7

1.5

37.50

57.40

ug/l

—

220

Superficial injury of wrist and hand

275

3479

0.79

3.83

1.4

1.5

55.42

60.47

ug/l

1.57

275

3479

Primary_lymphoid and hematopoietic malignant neoplasms

607

0.49

3.82

1.9

1.5

61.99

59.61

ug/l

0.11

607

Diseases of pulp and periapical tissues, including avohilmo

1649

7705

1.11

3.75

1.5

58.77

61.04

ug/l

1.17

1649

7705

Other disorders of fluid, electrolyte and acid-base balance

715

0.55

3.72

1.5

67.14

59.55

ug/l

0.32

715

Haemorrhage from respiratory passages

1198

0.66

3.72

1.4

1.5

58.57

60.60

ug/l

0.17

1198

Family history of other specific disorders

219

1.94

3.70

1.7

1.6

62.13

54.35

ug/l

0.71

219

Schizotypal disorder

203

0.24

3.69

1.2

1.6

58.73

54.58

ug/l

—

203

Anxious personality disorder

385

0.38

3.69

1.8

1.6

58.68

59.93

ug/l

0.04

385

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

297

1.77

3.69

1.6

1.5

55.25

61.14

ug/l

0.49

297

Type 1 diabetes, wide definition

183

2425

0.75

3.67

1.5

68.60

60.47

ug/l

1.30

183

2425

Fracture of forearm

490

5236

0.84

3.67

1.5

58.83

60.33

ug/l

0.31

490

5236

Open wound of forearm

978

0.61

3.66

1.4

1.6

60.37

59.85

ug/l

0.02

978

Migraine

1232

8575

1.12

3.66

1.5

60.02

60.19

ug/l

0.05

1232

8575

Type 1 diabetes, definitions combined

108

1548

0.69

3.64

1.5

68.82

61.00

ug/l

1.09

108

1548

Type 1 diabetes, strict (exclude DM2)

108

1548

0.69

3.64

1.5

68.82

61.00

ug/l

1.09

108

1548

Cardiovascular diseases

1494

8770

0.90

3.63

1.5

59.85

60.17

ug/l

0.10

1494

8770

Open wound of lower leg

1317

0.66

3.62

1.4

1.5

62.89

60.48

ug/l

0.22

1317

Other diseases of pleura

653

0.56

3.59

1.4

1.5

50.34

59.26

ug/l

1.00

653

Malignant neoplasm of skin

502

0.55

3.58

1.5

51.96

58.04

ug/l

0.60

502

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1156

0.64

3.57

1.4

1.5

62.10

60.87

ug/l

0.10

1156

Cough

309

3574

0.80

3.56

1.5

54.88

61.06

ug/l

2.14

309

3574

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

968

0.61

3.54

1.3

1.6

53.63

59.79

ug/l

0.59

968

Glucagon-like peptide-1 (GLP-1) analogues

911

0.60

3.54

1.4

1.5

38.12

61.53

ug/l

7.46

911

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

911

0.60

3.54

1.4

1.5

38.12

61.53

ug/l

7.46

911

Fracture of skull and facial bones

107

1536

0.69

3.53

1.5

59.30

60.12

ug/l

0.07

107

1536

Symptoms and signs involving the skin and subcutaneous tissue

700

7614

0.87

3.52

1.5

57.67

60.51

ug/l

1.07

700

7614

Type 1 diabetes, wide definition, subgroup 1

181

2385

0.75

3.51

1.5

68.52

60.44

ug/l

1.26

181

2385

Soft tissue disorders

1509

8536

0.90

3.51

1.5

59.20

60.38

ug/l

0.45

1509

8536

Fibromyalgia

1125

0.64

3.50

1.3

1.5

62.85

60.90

ug/l

0.10

1125

Other disorders of binocular movement

404

1.65

3.49

1.6

54.95

57.51

ug/l

0.19

404

Other metabolic disorders

1234

0.66

3.49

1.4

1.5

63.53

60.46

ug/l

0.28

1234

Follow-up care involving plastic surgery

214

0.28

3.48

1.0

1.5

48.13

55.58

ug/l

—

214

Mixed disorders of conduct and emotions, excluding more controls

902

0.60

3.48

1.6

54.88

59.00

ug/l

0.37

902

Pneumonia derived septicemia

222

1.87

3.48

1.7

1.6

49.44

56.28

ug/l

0.54

222

Unspecified haematuria

960

0.65

3.48

1.5

58.94

60.10

ug/l

0.08

960

Hallux valgus (acquired)

930

0.67

3.46

1.4

1.5

52.43

61.26

ug/l

1.50

930

Oter anti-inflammatory and antirheumatic agents, non-steroids

281

0.47

3.45

1.2

1.5

60.25

69.00

ug/l

0.51

281

Dialysis, with operation codes

304

0.33

3.42

1.4

1.6

109.16

57.26

ug/l

—

304

Rheumatoid arthritis

124

1530

0.72

3.42

1.5

60.50

60.03

ug/l

0.04

124

1530

Hypertrophy of breast

139

1896

0.73

3.41

1.4

1.5

55.05

59.23

ug/l

0.49

139

1896

Transplanted organ and tissue status

333

0.36

3.41

1.3

1.6

107.91

56.47

ug/l

1.21

333

Hypertrophy of breast in women and men

139

1896

0.73

3.40

1.4

1.5

55.05

59.23

ug/l

0.49

139

1896

Other menopausal disorders

101

818

0.69

3.40

1.2

1.4

62.44

59.08

ug/l

0.32

101

818

Specific development disorders of speech and language

1003

0.63

3.39

1.6

56.02

59.56

ug/l

0.35

1003

Type 1 diabetes

203

2620

0.77

3.39

1.5

67.61

60.37

ug/l

1.23

203

2620

Non-selective monoamine reuptake inhibitors

1282

0.68

3.38

1.4

1.5

53.91

60.89

ug/l

1.21

1282

Other anaemias

1294

0.69

3.37

1.6

1.5

66.00

59.93

ug/l

0.70

1294

Anogenital herpesviral [herpes simplex] infection

113

1581

0.70

3.36

1.7

1.5

60.57

60.28

ug/l

0.02

113

1581

Other and unspecified anaemias

1284

0.69

3.33

1.6

1.5

65.94

60.03

ug/l

0.67

1284

Postmenopausal bleeding

0.00

3.33

0.0

1.4

—

49.12

—

Implicit bacterial Sepsis

875

0.64

3.33

1.4

1.5

55.46

60.23

ug/l

0.56

875

Coxarthrosis [arthrosis of hip](FG)

345

0.48

3.33

1.4

1.5

74.99

57.11

ug/l

0.35

345

MS-disease / Multiple Sclerosis

1011

0.64

3.30

1.3

1.5

52.01

60.29

ug/l

1.55

1011

Preparatory care for dialysis

0.00

3.29

0.0

1.5

—

57.26

—

Injuries to unspecified part of trunk, limb or body region

889

0.61

3.28

1.5

68.22

59.55

ug/l

0.53

889

Routine general health check-up of defined subpopulation

308

0.35

3.26

1.5

68.85

61.24

ug/l

0.21

308

Anankastic personality disorder

671

0.56

3.26

1.4

1.5

53.56

58.95

ug/l

0.39

671

Specific developmental disorder of motor function

242

0.35

3.26

1.4

1.6

81.34

59.22

ug/l

—

242

Hypertrichosis

652

0.55

3.25

1.5

46.71

61.12

ug/l

2.02

652

Recurrent or chronic depression

499

4069

0.85

3.23

1.4

1.6

57.04

59.98

ug/l

0.84

499

4069

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

735

0.58

3.22

1.5

65.31

62.61

ug/l

0.13

735

Alcohol abuse, main dg

100

1424

0.70

3.21

1.4

1.6

57.28

60.00

ug/l

0.25

100

1424

Care involving dialysis

203

0.29

3.20

1.3

1.6

111.57

54.11

ug/l

—

203

Malignant neoplasm of brain, including Hilmo

218

0.32

3.19

1.3

1.6

53.64

56.27

ug/l

—

218

Hirsutism in women

608

0.54

3.17

1.4

1.5

47.86

60.55

ug/l

1.53

608

Diverticular disease of intestine

653

0.65

3.14

1.4

1.5

59.40

60.21

ug/l

0.05

653

Monoamine oxidase A inhibitors

499

0.50

3.14

1.4

1.5

55.57

60.88

ug/l

0.31

499

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

199

0.30

3.12

1.3

1.6

53.96

54.29

ug/l

—

199

Convulsions, not elsewhere classified

242

2989

0.80

3.11

1.5

55.68

60.25

ug/l

1.15

242

2989

Mental retardation, wide definition

342

0.40

3.11

1.4

1.6

40.56

56.42

ug/l

0.83

342

Conjunctivitis

1054

9445

0.90

3.10

1.5

61.25

59.93

ug/l

0.45

1054

9445

Mental retardation

340

0.40

3.08

1.4

1.6

40.56

56.48

ug/l

0.83

340

Hodgkin lymphoma, hilmo

246

0.36

3.07

1.2

1.6

87.94

54.72

ug/l

—

246

Fracture of lower leg, including ankle

368

4326

0.83

3.06

1.5

57.77

60.84

ug/l

0.70

368

4326

Other inflammation of vagina/vulva

878

0.63

3.05

1.6

1.5

65.78

59.78

ug/l

0.45

878

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1026

0.66

3.03

1.4

1.6

58.67

60.26

ug/l

0.12

1026

Other disorders starting during childhood or adolecense, excluding more controls

131

1671

0.73

3.02

1.5

1.6

61.99

61.03

ug/l

0.08

131

1671

Event of undetermined intent

720

0.59

3.01

1.5

61.34

61.31

ug/l

0.00

720

Other orthopaedic follow-up care

297

0.37

3.00

1.5

68.18

58.90

ug/l

0.32

297

Streptococcal septicaemia

278

1.70

2.99

1.5

1.6

57.13

58.22

ug/l

0.06

278

Spirochaetal infections, other/unspecified

354

0.42

2.99

1.7

1.6

47.28

59.13

ug/l

0.70

354

Superficial injury of lower leg

283

3462

0.81

2.98

1.4

1.5

56.21

60.47

ug/l

1.04

283

3462

Motor disorders

241

0.36

2.98

1.4

1.6

81.34

59.05

ug/l

—

241

Manic episode

351

0.42

2.97

1.3

1.6

92.35

58.77

ug/l

1.31

351

Asthma, hospital admissions , main diagnosis only

973

9436

0.89

2.97

1.5

57.86

60.33

ug/l

0.99

973

9436

Necrosis of pulp, including avohilmo

814

7128

1.13

2.97

1.5

57.64

60.06

ug/l

0.90

814

7128

Other disorders of skin and subcutaneous tissue

438

4352

0.85

2.96

1.4

1.5

58.46

60.01

ug/l

0.30

438

4352

Injury of other and unspecified intrathoracic organs

177

0.28

2.96

1.4

1.6

104.80

53.41

ug/l

—

177

Emotional disorders starting during childhood or adolecense, excluding more controls

167

2081

0.76

2.96

1.5

1.6

57.66

60.94

ug/l

0.44

167

2081

Symptoms and signs involving the nervous and musculoskeletal systems

436

5126

0.85

2.95

1.5

58.54

60.21

ug/l

0.38

436

5126

Neurological diseases

1415

7797

0.91

2.95

1.5

59.20

60.56

ug/l

0.56

1415

7797

Chronic gastritis

501

0.52

2.94

1.4

1.5

56.41

58.47

ug/l

0.14

501

Sequelae of cerebrovascular disease

325

0.45

2.93

1.4

1.5

46.51

57.00

ug/l

0.81

325

Chronic periodontitis, complicated

137

1782

0.75

2.93

1.6

1.5

62.40

59.77

ug/l

0.24

137

1782

Arthropathies

1551

8560

0.91

2.92

1.5

58.45

60.52

ug/l

1.14

1551

8560

Herpesviral [herpes simplex] infections, including avohilmo

367

4368

0.84

2.91

1.5

60.14

60.36

ug/l

0.04

367

4368

All chronic kidney diseases

252

2488

0.81

2.91

1.5

70.61

59.86

ug/l

2.46

252

2488

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1195

8405

1.11

2.90

1.5

59.59

60.27

ug/l

0.22

1195

8405

Dorsalgia

1439

8349

0.91

2.90

1.5

57.75

60.67

ug/l

1.84

1439

8349

Hydronephrosis

583

1.47

2.89

1.6

1.5

66.19

60.70

ug/l

0.44

583

Toxic effects of substances chiefly nonmedicinal as to source

1334

0.71

2.87

1.5

1.6

60.95

59.33

ug/l

0.10

1334

Systemic connective tissue disorders

185

2364

0.78

2.87

1.5

65.81

59.53

ug/l

0.76

185

2364

Other infective otitis externa

442

0.49

2.87

1.5

59.05

60.55

ug/l

0.07

442

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

157

0.36

2.87

1.6

1.5

58.20

57.73

ug/l

—

157

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

369

4230

0.84

2.86

1.5

57.70

60.03

ug/l

0.49

369

4230

Chronic diseases of tonsils and adenoids

1295

7423

1.10

2.83

1.5

58.39

60.70

ug/l

1.09

1295

7423

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1138

9387

1.11

2.82

1.5

61.46

59.89

ug/l

0.53

1138

9387

Contact with other sharp object(s)

1009

0.67

2.81

1.4

1.6

52.67

58.83

ug/l

0.85

1009

Crossbite

995

0.68

2.81

1.6

1.5

59.81

59.09

ug/l

0.06

995

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

149

1932

0.76

2.80

1.4

1.6

67.23

59.94

ug/l

0.66

149

1932

Syncope and collapse

339

3385

0.83

2.79

1.5

58.46

60.54

ug/l

0.39

339

3385

Behavioural disorders, excluding more controls

534

0.55

2.78

1.3

1.6

47.35

58.60

ug/l

1.22

534

Other systemic involvement of connective tissue (FG)

148

1900

0.76

2.77

1.5

65.66

59.34

ug/l

0.61

148

1900

Sleep disorders, other/unspecified

626

0.58

2.77

1.5

1.6

51.32

58.67

ug/l

0.97

626

Somatoform disorder

158

2045

0.77

2.77

1.5

55.55

59.33

ug/l

0.68

158

2045

Recurrent dislocation and subluxation of joint

691

0.60

2.76

1.5

65.34

62.25

ug/l

0.15

691

Migraine with aura and triptan purchases

387

4551

0.84

2.75

1.4

1.5

55.44

60.96

ug/l

1.60

387

4551

Other functional intestinal disorders

318

3468

0.83

2.75

1.5

57.90

59.87

ug/l

0.33

318

3468

Convalescence

354

0.45

2.75

1.5

56.32

57.78

ug/l

0.05

354

Other enthesopathies

135

1783

0.75

2.72

1.4

1.5

55.96

60.20

ug/l

0.59

135

1783

Diseases of liver

1312

0.71

2.72

1.4

1.5

52.52

60.96

ug/l

1.33

1312

Mental and behavioural disorders due to sedatives or hypnotics

575

0.57

2.71

1.3

1.5

58.44

59.78

ug/l

0.07

575

Other systemic involvement of connective tissue

148

1927

0.77

2.69

1.5

65.66

59.50

ug/l

0.59

148

1927

Heart failure, strict

256

0.46

2.68

1.3

1.5

60.47

57.72

ug/l

0.07

256

Heart failure,strict

257

0.46

2.68

1.3

1.5

60.47

57.67

ug/l

0.08

257

Other symptoms and signs involving cognitive functions and awareness

130

1527

0.75

2.66

1.4

1.5

56.33

59.56

ug/l

0.35

130

1527

Cutaneous abscess, furuncle and carbuncle

237

2914

0.81

2.66

1.5

53.99

60.01

ug/l

1.88

237

2914

Medical observation and evaluation for suspected diseases and conditions

866

4949

0.89

2.65

1.6

1.5

56.81

61.03

ug/l

2.07

866

4949

Anogenital herpesviral [herpes simplex] infection, including avohilmo

285

3426

0.82

2.65

1.5

60.80

60.00

ug/l

0.12

285

3426

Substance use, excluding alcohol

171

2178

0.78

2.64

1.4

1.5

53.90

59.67

ug/l

1.21

171

2178

Insulin, combination of fast acting with intermediate-acting or long-acting

449

3492

1.17

2.64

1.6

1.5

54.94

60.07

ug/l

1.73

449

3492

Haemorrhoids and perianal venous thrombosis

235

1888

1.24

2.63

1.5

58.93

60.45

ug/l

0.20

235

1888

Fracture at wrist and hand level

281

3382

0.83

2.63

1.5

57.02

60.78

ug/l

0.74

281

3382

Malignant neoplasm of digestive organs

236

0.42

2.62

1.5

56.32

54.95

ug/l

0.04

236

Diseases of the ear and mastoid process

1551

8441

0.92

2.60

1.5

58.53

60.56

ug/l

1.03

1551

8441

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

317

0.44

2.59

1.2

1.6

48.73

54.81

ug/l

0.34

317

Pulmonary heart disease, diseases of pulmonary circulation

754

0.64

2.58

1.5

45.39

59.80

ug/l

2.64

754

Intracranial injury

607

6420

0.88

2.58

1.5

56.12

60.27

ug/l

1.89

607

6420

Endometriosis ASRM stages 1,2

359

3043

1.19

2.56

1.4

1.5

62.41

59.33

ug/l

0.71

359

3043

Endometriosis of intestine

392

0.50

2.55

1.4

1.5

55.06

60.98

ug/l

0.35

392

Demyelinating diseases of the central nervous system

1129

0.70

2.55

1.4

1.5

53.78

60.13

ug/l

0.77

1129

Malignant neoplasm of eye, brain and central nervous system

180

0.33

2.54

1.3

1.5

53.16

53.38

ug/l

—

180

150

1.89

2.53

1.4

1.5

74.08

53.18

ug/l

1.22

150

Certain conditions originating in the perinatal period

205

2249

0.80

2.53

1.6

58.38

59.92

ug/l

0.23

205

2249

Mixed specific developmental disorders

374

0.51

2.51

1.3

1.6

42.16

59.45

ug/l

1.71

374

Myalgia

275

3307

0.83

2.50

1.5

63.15

60.48

ug/l

0.36

275

3307

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

215

2306

0.81

2.46

1.5

57.03

59.45

ug/l

0.42

215

2306

Diabetic nephropathy

465

0.55

2.46

1.4

1.6

91.59

49.58

ug/l

1.77

465

Injuries to the wrist and hand

1280

9246

0.92

2.45

1.5

57.01

60.47

ug/l

2.37

1280

9246

DVT of lower extremities and pulmonary embolism

1142

0.71

2.44

1.5

46.17

60.55

ug/l

4.60

1142

Schizoid personality disorder

0.00

2.43

0.0

1.6

—

50.52

—

Female infertility, uterine origin

2.38

2.43

1.3

1.5

59.94

55.92

ug/l

0.24

All-cause Heart Failure

246

0.48

2.43

1.3

1.5

60.47

57.78

ug/l

0.07

246

Scarlet fever, including avohilmo

132

1.96

2.42

1.7

1.6

57.73

50.53

ug/l

0.38

132

Venous thromboembolism

146

1806

0.78

2.42

1.5

51.54

59.20

ug/l

2.12

146

1806

Heart failure and antihypertensive medication

212

0.46

2.42

1.3

1.5

62.82

59.81

ug/l

0.07

212

Bacterial pneumonia, not elsewhere classified

191

2088

0.80

2.42

1.5

58.20

59.87

ug/l

0.23

191

2088

Spondylosis

879

0.71

2.42

1.3

1.5

52.52

60.60

ug/l

1.02

879

Kidney transplant status

204

0.39

2.41

1.4

1.6

115.19

54.29

ug/l

—

204

Chronic suppurative otitis media

554

0.59

2.40

1.5

1.6

60.53

60.57

ug/l

0.00

554

Congenital malformations of uterus and cervix

630

1.42

2.40

1.4

1.5

60.53

59.46

ug/l

0.08

630

Other shoulder lesions

811

0.66

2.40

1.5

60.15

59.83

ug/l

0.02

811

Infective dermatitis

708

1.38

2.40

1.6

1.5

60.65

59.52

ug/l

0.09

708

Superficial injury of ankle and foot

185

2301

0.80

2.40

1.5

1.6

58.55

60.17

ug/l

0.21

185

2301

Focal epilepsy

122

1598

0.76

2.38

1.4

1.5

57.63

59.95

ug/l

0.28

122

1598

Streptococcal septicaemia, including avohilmo

297

1.59

2.38

1.5

1.6

57.13

59.14

ug/l

0.12

297

Focal epilepsy, strict definition

1323

0.74

2.37

1.4

1.5

55.57

59.60

ug/l

0.57

1323

Soft tissue disorders related to use, overuse and pressure

1058

0.71

2.36

1.3

1.5

61.19

60.46

ug/l

0.04

1058

Other disorders of bone

157

1988

0.79

2.35

1.4

1.5

58.68

60.16

ug/l

0.16

157

1988

Agranulocytosis

489

0.57

2.35

1.6

1.5

61.10

59.30

ug/l

0.13

489

Complications of anaesthesia during labour and delivery

2.20

2.34

1.9

1.5

51.74

56.30

ug/l

0.24

Malignant neoplasm of breast, ER-negative, including Hilmo

527

0.60

2.32

1.3

1.5

79.37

57.36

ug/l

1.54

527

Delayed milestone in childhood

170

0.36

2.32

1.3

1.5

51.92

55.84

ug/l

—

170

Disorders of breast

709

6963

0.89

2.32

1.5

60.41

59.99

ug/l

0.10

709

6963

Benign neoplasm: Female genital organ, unspecified

3.66

2.32

1.9

1.5

57.93

66.20

ug/l

—

Conjunctivitis (acute, non atopic)

338

3944

0.85

2.31

1.5

58.16

60.11

ug/l

0.38

338

3944

Nonalcoholic fatty liver disease

461

0.56

2.31

1.4

1.5

44.04

59.30

ug/l

1.75

461

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

344

0.49

2.31

1.4

1.5

68.36

57.18

ug/l

0.36

344

HSIL lesion of the cervix uteri, vagina or vulva

463

5291

0.87

2.30

1.5

58.93

59.75

ug/l

0.15

463

5291

Secondary uncertain malignant neoplasm

289

0.45

2.29

1.5

1.6

80.43

55.62

ug/l

0.79

289

Injury of muscle and tendon at hip and thigh level

510

0.59

2.29

1.6

1.5

78.13

59.85

ug/l

0.91

510

Malignant neoplasm of digestive organs, including Hilmo

283

0.52

2.29

1.5

59.85

57.71

ug/l

0.08

283

Malignant neoplasm of brain

155

0.32

2.28

1.2

1.6

54.67

52.21

ug/l

—

155

Mixed disorders of conduct and emotions

816

0.67

2.28

1.6

54.88

60.02

ug/l

0.50

816

Other facial nerve disorders

172

0.35

2.28

1.3

1.6

70.63

55.90

ug/l

—

172

Secondary and unspecified malignant neoplasm of lymph nodes

260

0.42

2.27

1.5

1.6

77.06

54.84

ug/l

0.55

260

Chronic kidney disease

429

0.56

2.26

1.4

1.5

109.84

58.40

ug/l

2.64

429

Mental and behavioural disorders due to opioids

567

0.61

2.25

1.2

1.5

54.68

59.21

ug/l

0.28

567

Toxic effect of ethanol

530

0.60

2.25

1.5

51.72

59.31

ug/l

0.76

530

malignant neoplasm of female genital organs

472

0.58

2.25

1.4

1.5

70.94

57.65

ug/l

0.60

472

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

454

0.57

2.24

1.5

1.6

57.16

57.41

ug/l

0.01

454

Irregular menses

1117

9138

0.91

2.24

1.5

61.55

60.10

ug/l

0.46

1117

9138

Valvular heart disease excluding rheumatic fever

891

0.74

2.23

1.5

69.95

60.57

ug/l

1.25

891

Diarrhoea and gastroenteritis of presumed infectious origin

875

8604

0.91

2.23

1.5

60.05

60.02

ug/l

0.01

875

8604

Venous complications and haemorrhoids in the puerperium

129

1.91

2.22

1.9

1.6

47.31

54.20

ug/l

0.58

129

Anorexia (incl.atypical)

151

1893

0.79

2.22

1.5

1.6

71.34

59.99

ug/l

1.58

151

1893

Other sleep disorders

1077

0.72

2.21

1.4

1.6

54.98

60.42

ug/l

0.74

1077

Other inflammation of eyelid

949

0.70

2.20

1.5

63.18

60.26

ug/l

0.16

949

Childhood allergy (age < 16)

694

6351

0.89

2.20

1.5

1.6

62.83

59.77

ug/l

0.88

694

6351

Toxic effect of other and unspecified substances

180

0.38

2.20

1.6

1.5

51.16

52.42

ug/l

—

180

Pulmonary embolism

688

0.65

2.19

1.5

45.75

59.24

ug/l

2.26

688

Pulmonary heart disease

688

0.65

2.19

1.5

45.75

59.24

ug/l

2.26

688

1554

7299

1.08

2.19

1.5

58.60

61.02

ug/l

1.36

1554

7299

Gonococcal infection, including avohilmo

214

0.42

2.19

1.4

1.6

46.92

52.64

ug/l

—

214

Focal epilepsy, mode (most common among epilepsy diagnosis)

100

1326

0.75

2.17

1.5

1.6

54.44

59.46

ug/l

0.79

100

1326

Diabetic retinopathy, strict definition

104

692

1.34

2.16

1.5

1.6

66.22

49.46

ug/l

2.48

104

692

Fracture of foot, except ankle

275

3257

0.84

2.16

1.5

59.68

60.41

ug/l

0.08

275

3257

Enterobiasis, including avohilmo

694

1.38

2.16

1.6

1.5

54.77

59.76

ug/l

0.60

694

Bacterial pneumoniae

211

2250

0.82

2.15

1.5

58.30

59.76

ug/l

0.21

211

2250

Benign neoplasm: Liver/bile ducts

252

0.43

2.15

1.5

1.6

77.82

55.97

ug/l

0.94

252

Allergic colitis

505

1.44

2.15

1.6

55.64

58.23

ug/l

0.22

505

Sleep disorders (combined)

1434

8082

0.92

2.14

1.4

1.5

58.92

60.34

ug/l

0.59

1434

8082

Sciatica+with lumbago

408

4151

0.87

2.14

1.5

55.26

60.12

ug/l

1.53

408

4151

Hernia of abdominal wall, postoperative

701

1.35

2.12

1.6

1.5

59.45

59.68

ug/l

0.02

701

Enterocolitis due to Clostridium difficile

385

0.54

2.12

1.6

59.42

59.27

ug/l

0.01

385

Pruritus

161

1287

1.26

2.12

1.6

66.83

59.93

ug/l

0.85

161

1287

Viral hepatitis, IBD co-morbidity

692

0.66

2.12

1.3

1.5

51.78

62.26

ug/l

0.99

692

Nonsuppurative otitis media

660

6368

0.89

2.12

1.6

58.46

60.39

ug/l

0.56

660

6368

Sequelae of injuries, of poisoning and of other consequences of external causes

126

1615

0.78

2.12

1.4

1.5

58.55

59.99

ug/l

0.14

126

1615

Excessive, frequent and irregular menstruation

997

5820

0.91

2.11

1.5

62.01

60.08

ug/l

0.61

997

5820

Other bacterial intestinal infections, including avohilmo

136

1726

0.79

2.11

1.5

56.99

60.01

ug/l

0.43

136

1726

Other acute lower respiratory infections

505

5439

0.88

2.10

1.5

55.39

60.53

ug/l

2.33

505

5439

Diseases of salivary glands

259

3076

0.84

2.10

1.5

60.15

59.54

ug/l

0.09

259

3076

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

264

0.45

2.09

1.4

1.5

48.75

59.11

ug/l

0.65

264

Superficial injury of forearm

123

1575

0.78

2.09

1.6

56.08

59.67

ug/l

0.38

123

1575

Volume depletion

291

0.48

2.09

1.8

1.6

41.53

56.24

ug/l

1.44

291

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

213

1732

1.22

2.08

1.5

1.6

51.07

59.59

ug/l

2.35

213

1732

Non-rheumatic valve diseases

870

0.75

2.06

1.5

69.92

60.34

ug/l

1.27

870

Carrier of infectious disease

340

0.52

2.06

1.7

1.6

48.87

54.62

ug/l

0.28

340

Deep bite

121

1362

0.77

2.06

1.5

55.49

60.71

ug/l

0.99

121

1362

Complications of anaesthesia during pregnancy

2.58

2.06

1.4

59.51

64.69

ug/l

0.24

Other arrhythmias

520

4382

0.88

2.06

1.4

1.5

60.10

59.94

ug/l

0.03

520

4382

L04AC Interleukin inhibitors

591

0.64

2.05

1.4

1.5

57.37

60.56

ug/l

0.21

591

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

319

0.59

2.05

1.5

57.24

55.61

ug/l

0.10

319

Polyneuropathies and other disorders of the peripheral nervous system

419

0.57

2.05

1.4

1.5

61.30

58.70

ug/l

0.15

419

HSIL lesion of the cervix uteri

458

5188

0.88

2.04

1.5

59.14

59.69

ug/l

0.09

458

5188

malignant neoplasm of female genital organs, including Hilmo

562

0.64

2.01

1.3

1.5

74.81

58.24

ug/l

1.08

562

Fibroblastic disorders

541

0.63

2.01

1.4

1.5

59.28

59.88

ug/l

0.03

541

Anxiety disorders

1169

8678

0.92

1.99

1.5

58.79

60.29

ug/l

0.57

1169

8678

Glomerular diseases

825

0.70

1.98

1.4

1.5

83.33

59.80

ug/l

1.87

825

Disorders of speech understanding and production

572

0.64

1.97

1.5

1.6

60.06

57.57

ug/l

0.14

572

Other rupture of muscle

2.51

1.95

1.7

1.6

69.86

54.70

ug/l

0.36

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

236

0.45

1.95

1.1

1.5

80.62

56.61

ug/l

0.62

236

L02BG Aromatase inhibitors

126

975

1.28

1.95

1.5

58.25

60.05

ug/l

0.20

126

975

Caries of dentine, including avohilmo

773

3572

1.11

1.95

1.5

58.50

61.31

ug/l

1.03

773

3572

Neoplasms

1522

8557

0.93

1.95

1.5

59.97

60.16

ug/l

0.05

1522

8557

Bacterial Sepsis

136

1414

0.79

1.95

1.5

57.58

60.14

ug/l

0.33

136

1414

Benign neoplasm: Liver

241

0.45

1.94

1.5

1.6

77.82

55.32

ug/l

0.97

241

Combinations of oral blood glucose lowering drugs

204

0.44

1.94

1.7

1.5

35.33

57.19

ug/l

—

204

Defect, injury or illness of lumbar spine

0.00

1.93

0.0

1.5

—

50.54

—

Other enthesopathy of foot (+metatarsalgia)

842

0.71

1.92

1.5

56.93

61.46

ug/l

0.33

842

Inflammatory diseases of the central nervous system

545

0.64

1.91

1.8

1.5

50.20

59.44

ug/l

1.16

545

Benign neoplasm of breast

980

0.73

1.91

1.5

58.92

59.55

ug/l

0.06

980

Pyogenic granuloma

181

1.69

1.91

1.6

1.5

54.03

55.11

ug/l

0.04

181

Other joint disorders

1533

8560

0.93

1.91

1.5

57.71

60.52

ug/l

1.73

1533

8560

Hypertrophy of (infrapatellar) fat pad

2.20

1.90

1.2

1.6

85.36

50.08

ug/l

0.98

Other benign neoplasms of uterus

1.97

1.90

1.3

1.5

45.73

51.72

ug/l

0.28

Obstructed labour due to maternal pelvic abnormality

422

1.43

1.90

1.6

1.5

55.51

60.21

ug/l

0.39

422

Presence of cardiac and vascular implants and grafts

217

0.51

1.89

1.3

1.5

66.37

54.66

ug/l

0.60

217

Migraine with aura

580

6445

0.90

1.89

1.5

57.06

60.05

ug/l

0.92

580

6445

Other benign neoplasm of uterus: Corpus uteri

2.44

1.87

1.5

1.6

41.54

50.22

ug/l

0.56

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

197

1.64

1.87

1.3

1.5

69.56

56.34

ug/l

0.97

197

Hyperparathyroidism

236

0.46

1.87

1.3

1.5

90.26

57.08

ug/l

0.83

236

Intestinal adhesions without obstruction

143

0.35

1.86

1.4

1.6

54.66

51.94

ug/l

—

143

Intentional self-harm by unspecified means

287

0.51

1.85

1.3

1.6

61.51

56.40

ug/l

0.13

287

Benign neoplasm of mouth and pharynx

443

0.61

1.85

1.7

1.6

51.40

59.41

ug/l

0.55

443

Contusion of ankle

634

0.67

1.85

1.5

1.6

64.36

61.84

ug/l

0.12

634

Speech therapy

1010

0.74

1.85

1.4

1.5

65.89

59.79

ug/l

0.52

1010

Tobacco use

587

1.36

1.85

1.4

1.5

52.00

60.33

ug/l

1.03

587

Chromosomal abnormalities, not elsewhere classified

310

1.51

1.85

1.6

1.5

53.14

56.61

ug/l

0.26

310

Hyperkinetic disorders (excl. ADHD)

284

0.51

1.85

1.6

54.29

53.99

ug/l

0.01

284

Scabies, including avohilmo

220

2609

0.84

1.84

1.5

56.42

60.24

ug/l

0.76

220

2609

Persons encountering health services in other circumstances

748

6738

1.10

1.84

1.5

56.31

60.09

ug/l

1.79

748

6738

Impacted teeth

897

7076

1.10

1.84

1.5

1.6

62.15

59.64

ug/l

0.86

897

7076

Benign neoplasm of other and ill-defined parts of digestive system

479

0.62

1.83

1.4

1.5

60.15

59.48

ug/l

0.03

479

Ocular pain

1051

0.75

1.83

1.5

71.21

59.63

ug/l

1.15

1051

Polycystic ovarian syndrome

307

2667

1.17

1.82

1.5

1.6

57.07

59.85

ug/l

0.48

307

2667

Other and unspecified effects of external causes

391

4441

0.88

1.82

1.5

55.89

60.50

ug/l

1.48

391

4441

Diseases of the skin and subcutaneous tissue

1292

6971

0.93

1.81

1.5

59.54

59.94

ug/l

0.11

1292

6971

Covid-19 suspected case

322

3702

0.87

1.80

1.5

57.50

60.09

ug/l

0.53

322

3702

Neurotic, stress-related and somatoform disorders

1170

8678

0.93

1.80

1.5

58.83

60.29

ug/l

0.55

1170

8678

Bacterial pneumonia (organism specified)

221

2372

0.84

1.79

1.5

57.88

59.58

ug/l

0.26

221

2372

Paroxysmal tachycardia

163

1651

0.82

1.79

1.5

62.01

59.84

ug/l

0.25

163

1651

Insulin, fast-acting or short human

228

2692

0.84

1.79

1.5

64.61

59.55

ug/l

0.81

228

2692

Open wound of shoulder and upper arm

169

0.41

1.79

1.6

98.59

53.56

ug/l

—

169

Colectomy operation

339

0.56

1.79

1.7

1.6

49.90

59.42

ug/l

0.51

339

Trochanteric bursitis

500

0.64

1.79

1.4

1.5

57.78

62.58

ug/l

0.22

500

Melanocytic naevi, other sites/unspecified

112

879

1.28

1.78

1.6

1.5

73.99

60.17

ug/l

1.04

112

879

Other benign neoplasms of skin

234

1981

1.18

1.77

1.5

57.70

59.59

ug/l

0.28

234

1981

Metatarsalgia

782

0.71

1.77

1.5

57.48

61.21

ug/l

0.24

782

FESS (DNB20)

113

888

1.28

1.77

1.5

47.38

60.36

ug/l

5.15

113

888

Injury of unspecified body region

629

0.68

1.77

1.4

1.6

67.47

60.45

ug/l

0.34

629

Pneumothorax

151

0.40

1.76

1.2

1.6

52.25

52.33

ug/l

—

151

Visual impairment including blindness (binocular or monocular)

298

0.53

1.76

1.5

51.91

54.97

ug/l

0.14

298

Special screening examination for other diseases and disorders

170

1399

1.22

1.75

1.5

61.67

61.06

ug/l

0.06

170

1399

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

707

6443

1.10

1.75

1.5

56.61

60.35

ug/l

1.54

707

6443

Basal cell carcinoma, including Hilmo

281

0.60

1.75

1.5

58.23

56.50

ug/l

0.10

281

Algoneurodystrophy

335

0.56

1.75

1.4

1.6

53.21

56.37

ug/l

0.10

335

Other and unspecified injuries of wrist and hand

471

0.63

1.75

1.4

1.5

57.98

61.53

ug/l

0.17

471

Seronegative rheumatoid arthritis

448

0.62

1.74

1.5

62.52

57.76

ug/l

0.24

448

Asthma, excluding more controls

982

5467

0.92

1.74

1.5

58.34

61.75

ug/l

1.55

982

5467

Optic neuritis

566

0.66

1.74

1.6

1.5

45.61

60.03

ug/l

2.20

566

Extrapyramidal and movement disorders

121

1516

0.80

1.74

1.4

1.5

53.91

60.06

ug/l

1.22

121

1516

Exclusions for E4_PCOS_BROAD

135

1667

0.81

1.73

1.4

1.5

58.57

59.70

ug/l

0.13

135

1667

Mild mental retardation

243

0.49

1.73

1.5

1.6

42.31

55.89

ug/l

0.58

243

Use of pramipexole

508

0.65

1.73

1.3

1.5

55.69

59.40

ug/l

0.25

508

COPD differential diagnosis

1017

5518

0.92

1.73

1.5

57.17

61.74

ug/l

2.76

1017

5518

Retention of urine

864

0.76

1.73

1.5

60.86

59.52

ug/l

0.11

864

Dermatitis due to substances taken internally

566

0.67

1.73

1.6

65.81

59.14

ug/l

0.46

566

Unspecified fall

410

4541

0.88

1.72

1.5

57.29

60.12

ug/l

0.77

410

4541

Total colectomy

243

0.49

1.72

1.6

50.08

53.13

ug/l

0.09

243

Total colectomy operation

243

0.49

1.72

1.6

50.08

53.13

ug/l

0.09

243

Hypertension, Pulmonary Arterial

0.00

1.72

0.0

1.6

—

53.79

—

Other viral hepatitis

683

0.70

1.71

1.3

1.5

52.05

60.14

ug/l

0.76

683

Tubulo-interstitial nephritis, not specified as acute or chronic

433

0.62

1.71

1.7

1.5

61.49

59.49

ug/l

0.11

433

Diabetic neuropathy

194

0.46

1.71

1.4

1.5

101.80

47.16

ug/l

—

194

Asthma mixed form (mode), excluding more controls

529

0.66

1.71

1.6

1.5

61.27

59.72

ug/l

0.08

529

Asthma mixed form (mode)

529

0.66

1.71

1.6

1.5

61.27

59.63

ug/l

0.09

529

Superficial injury of shoulder and upper arm

1108

0.76

1.71

1.5

58.04

60.37

ug/l

0.23

1108

Otitis externa, unspecified

1242

0.78

1.70

1.6

1.5

50.45

59.57

ug/l

1.77

1242

Adverse effects, not elsewhere classified

258

2999

0.86

1.70

1.5

55.64

59.68

ug/l

0.85

258

2999

Malignant neoplasm of breast, HER-negative

439

0.63

1.69

1.2

1.5

79.86

57.23

ug/l

1.35

439

Hyperkalaemia

0.00

1.69

0.0

1.5

—

49.70

—

ILD differential diagnosis

1017

5512

0.92

1.69

1.5

57.11

61.76

ug/l

2.85

1017

5512

Parasetamol

1330

6270

1.07

1.69

1.5

55.97

62.35

ug/l

6.82

1330

6270

Congenital malformations and deformations of the musculoskeletal system

130

1595

0.80

1.68

1.4

1.6

69.05

59.56

ug/l

0.81

130

1595

Disorders of parathyroid gland

341

0.58

1.68

1.2

1.5

72.38

57.09

ug/l

0.54

341

Asthma (only as main-diagnosis), excluding more controls

911

5467

0.92

1.68

1.5

57.91

61.75

ug/l

1.81

911

5467

Explicit Sepsis

316

2503

1.15

1.68

1.7

1.5

57.12

59.16

ug/l

0.45

316

2503

Conduct disorder

476

0.64

1.68

1.3

1.6

47.59

58.32

ug/l

1.18

476

Hypermobility syndrome

1213

0.77

1.68

1.5

62.33

60.31

ug/l

0.15

1213

Polyuria

856

0.73

1.68

1.5

64.10

59.95

ug/l

0.34

856

Psychotic depression

886

0.74

1.66

1.5

1.6

53.83

60.94

ug/l

0.69

886

Asthma-related infections

627

6722

0.91

1.66

1.5

55.29

60.26

ug/l

2.89

627

6722

Asthma, hospital admission 2, infections

627

6722

0.91

1.66

1.5

55.29

60.26

ug/l

2.89

627

6722

Radial styloid tenosynovitis [de Quervain]

695

1.31

1.65

1.4

1.5

58.26

61.26

ug/l

0.27

695

Noninflammatory disorders of female genital tract

1245

5825

1.08

1.65

1.5

59.72

60.06

ug/l

0.09

1245

5825

Conduction disorders

685

0.74

1.65

1.5

53.23

60.12

ug/l

0.77

685

Nail disorders

678

0.70

1.64

1.4

1.5

64.26

60.10

ug/l

0.26

678

Golimumab

353

0.59

1.64

1.1

1.5

57.33

57.67

ug/l

0.01

353

Diseases of pulp and periapical tissues and dental caries

592

2737

1.11

1.64

1.5

59.31

61.39

ug/l

0.53

592

2737

Dental caries, including avohilmo

634

2937

1.11

1.63

1.5

59.72

61.02

ug/l

0.31

634

2937

Viral and other specified intestinal infections

596

5280

1.11

1.63

1.5

61.85

59.91

ug/l

0.51

596

5280

Abnormal findings on diagnostic imaging of lung

631

0.70

1.62

1.4

1.5

59.53

58.96

ug/l

0.03

631

Asthma

982

5473

0.92

1.62

1.5

58.34

61.74

ug/l

1.55

982

5473

Gout

116

0.37

1.62

1.4

1.6

34.92

54.87

ug/l

—

116

Adjustment and management of implanted device

290

0.55

1.62

1.4

1.6

64.21

58.49

ug/l

0.16

290

Ethmoidectomy

113

900

1.26

1.61

1.5

47.38

60.84

ug/l

5.47

113

900

Disorders of optic nerve and visual pathways

1063

0.77

1.61

1.5

57.66

59.20

ug/l

0.10

1063

Hypertrophic scar

811

0.73

1.60

1.5

51.32

60.42

ug/l

1.34

811

Other condition

104

1309

0.79

1.60

1.4

1.6

59.53

59.29

ug/l

0.02

104

1309

L02BA Anti-estrogens

401

0.62

1.60

1.2

1.5

54.14

57.75

ug/l

0.23

401

Other and unspecified injuries of ankle and foot

741

0.72

1.59

1.5

54.89

61.32

ug/l

0.84

741

Overexertion and strenuous or repetitive movements

754

0.73

1.58

1.6

1.5

58.44

60.14

ug/l

0.11

754

Other pulmonary diagnosis

1018

5499

0.93

1.58

1.5

57.10

61.76

ug/l

2.86

1018

5499

Other special examinations and investigations of persons without complaint or reported diagnosis

902

4949

0.92

1.58

1.5

59.99

61.03

ug/l

0.29

902

4949

Nontoxic single thyroid nodule

399

0.62

1.58

1.4

1.5

60.95

58.37

ug/l

0.15

399

Injuries to the abdomen, lower back, lumbar spine and pelvis

350

3904

0.88

1.57

1.6

1.5

59.01

59.94

ug/l

0.15

350

3904

Atopic conjunctivitis

670

0.71

1.57

1.5

1.6

58.60

60.01

ug/l

0.09

670

Viral hepatitis

706

0.72

1.57

1.3

1.5

51.24

60.21

ug/l

0.90

706

Other and unspecified corneal deformities and disorders

129

1.72

1.57

1.5

1.6

57.27

53.75

ug/l

0.16

129

Mental and behavioural disorders due to use of other stimulants, including caffeine

433

0.64

1.57

1.3

1.5

50.08

57.34

ug/l

0.58

433

Pediculosis, acariasis and other infestations, including avohilmo

242

2804

0.86

1.56

1.5

58.15

60.27

ug/l

0.35

242

2804

D07AA Corticosteroids, weak (group I)

314

2751

1.15

1.56

1.5

1.6

61.14

60.23

ug/l

0.10

314

2751

Abnormal findings on examination of blood, without diagnosis

176

1897

0.84

1.56

1.5

54.78

59.56

ug/l

1.00

176

1897

Other viral hepatitis, including avohilmo

739

0.73

1.56

1.3

1.5

51.60

60.30

ug/l

0.95

739

Behavioural disorders

455

0.65

1.56

1.3

1.6

47.35

58.96

ug/l

1.26

455

Malignant melanoma of skin, including Hilmo

286

0.56

1.55

1.4

1.5

37.38

55.10

ug/l

1.67

286

All dysplastic lesions of the vagina

220

0.49

1.55

1.4

1.5

59.01

56.73

ug/l

0.06

220

Vitreous haemorrhage

311

0.58

1.55

1.3

1.6

87.22

58.69

ug/l

0.86

311

Degenerative diseases of the nervous system

0.00

1.54

0.0

1.5

—

53.73

—

Toxoplasmosis

0.00

1.54

0.0

1.6

—

51.80

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

1157

0.78

1.54

1.4

1.5

60.58

59.83

ug/l

0.07

1157

Acne vulgaris

254

2916

0.86

1.54

1.5

1.6

64.17

60.00

ug/l

0.67

254

2916

Toxoplasmosis, including avohilmo

0.00

1.54

0.0

1.6

—

51.25

—

Other gastritis (incl. Duodenitis)

750

0.73

1.53

1.5

66.06

60.95

ug/l

0.28

750

Reduction defects of lower limb, including avohilmo

0.00

1.53

0.0

1.5

—

53.64

—

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

1.85

1.53

1.5

59.20

51.29

ug/l

0.39

Toxic effect of organic solvents

0.00

1.52

0.0

1.6

—

50.44

—

Spinal stenosis

257

0.60

1.52

1.3

1.5

54.68

56.88

ug/l

0.12

257

Plantar fascial fibromatosis

468

0.66

1.52

1.4

1.5

58.41

59.16

ug/l

0.03

468

Diseases of external ear

235

2726

0.86

1.52

1.4

1.5

56.36

59.39

ug/l

0.49

235

2726

Other specified/unspecified systemic involvement of connective tissue

358

0.61

1.52

1.4

1.5

67.43

58.61

ug/l

0.20

358

Other infiltrative disorders of skin and subcutaneous tissue

2.92

1.52

1.7

1.5

49.37

53.61

ug/l

—

LeFortI or BSSO operation

626

1.31

1.52

1.4

1.5

56.18

59.88

ug/l

0.39

626

Tularaemia

1.93

1.51

1.5

1.6

47.77

51.73

ug/l

0.31

Viral hepatitis, including avohilmo

769

0.74

1.50

1.3

1.5

50.90

59.98

ug/l

1.04

769

Insulin, fast-acting

228

2646

0.86

1.50

1.5

64.61

59.91

ug/l

0.73

228

2646

Disturbances of skin sensation

336

3797

0.88

1.50

1.5

55.35

60.10

ug/l

1.69

336

3797

Fall on and from stairs and steps

176

2086

0.84

1.50

1.5

56.73

60.14

ug/l

0.50

176

2086

Accessory breast

117

1.77

1.50

1.4

1.5

49.06

52.04

ug/l

0.16

117

Alcohol-induced acute pancreatitis

0.00

1.50

0.0

1.5

—

47.76

—

Cyst of spleen

2.66

1.49

1.9

1.6

61.18

49.22

ug/l

—

Localized swelling, mass and lump of skin and subcutaneous tissue

203

2377

0.85

1.49

1.4

1.5

57.59

60.03

ug/l

0.40

203

2377

Diseases of the respiratory system

893

4835

0.92

1.49

1.5

58.08

61.77

ug/l

1.67

893

4835

Chronic suppurative otitis media, including avohilmo

687

0.72

1.49

1.6

56.64

60.39

ug/l

0.23

687

Sequelae of injuries of lower limb

606

0.71

1.48

1.4

1.5

55.28

60.60

ug/l

0.39

606

Hirsprung

3.40

1.48

1.0

1.4

89.04

47.96

ug/l

—

Peripheral artery disease

203

0.54

1.48

1.4

1.5

65.61

56.21

ug/l

0.24

203

Mandibular retrognathia

125

1018

1.23

1.47

1.5

58.16

60.07

ug/l

0.20

125

1018

Other diseases of intestine

281

0.57

1.47

1.3

1.5

75.26

57.50

ug/l

0.42

281

Congenital deformities of hip, including avohilmo

340

0.61

1.47

1.3

1.6

79.63

58.73

ug/l

0.37

340

Otitis externa

193

2265

0.85

1.47

1.5

53.40

59.82

ug/l

1.40

193

2265

Other diseases of arteries and capillaries

343

0.61

1.47

1.3

1.6

61.39

58.94

ug/l

0.10

343

Irritable bowel syndrome

324

3664

0.88

1.47

1.5

54.96

60.19

ug/l

1.57

324

3664

Helminthiases, including avohilmo

103

825

1.26

1.47

1.5

54.89

59.82

ug/l

0.65

103

825

Melanocytic naevi

462

4166

1.11

1.46

1.5

63.51

60.25

ug/l

0.66

462

4166

Other infectious diseases, including avohilmo

534

0.69

1.46

1.4

1.5

57.46

60.16

ug/l

0.19

534

Bitten or struck by other mammals

157

1871

0.83

1.46

1.5

54.62

60.48

ug/l

1.12

157

1871

Pedal cyclist injured in noncollision transport accidents

1125

0.79

1.45

1.5

1.6

66.67

59.59

ug/l

0.65

1125

Acute pharyngitis

311

3483

0.88

1.45

1.6

1.5

54.78

60.91

ug/l

2.02

311

3483

Ovarian dysfunction

346

3082

1.14

1.45

1.5

57.05

59.94

ug/l

0.54

346

3082

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

100

1247

0.80

1.45

1.4

1.6

58.64

59.05

ug/l

0.04

100

1247

Car occupant injured in other and unspecified transport accidents

349

3101

1.13

1.45

1.4

1.5

58.41

60.03

ug/l

0.27

349

3101

Chondropathies

129

1564

0.82

1.43

1.4

1.5

58.25

59.99

ug/l

0.18

129

1564

Fracture of shoulder and upper arm

199

2321

0.85

1.43

1.5

1.6

57.83

60.25

ug/l

0.33

199

2321

Mental and behavioural disorders of puerperium, not classified elsewhere

272

1.47

1.43

1.5

55.63

55.30

ug/l

0.02

272

Non-Hodgkin lymphoma, all, including Hilmo

154

0.45

1.42

2.1

1.5

46.16

51.86

ug/l

—

154

Bacterial intestinal infections, IBD co-morbidities

921

0.77

1.42

1.5

52.57

60.04

ug/l

1.37

921

Methotrexate

864

0.76

1.42

1.7

1.5

57.96

61.98

ug/l

0.47

864

Other symptoms and signs involving the urinary system

400

0.65

1.41

1.7

1.5

58.52

57.03

ug/l

0.06

400

Explicit bacterial Sepsis

596

1.30

1.41

1.6

1.5

59.88

61.59

ug/l

0.13

596

Hypoglycaemia, other or unspecified

506

0.69

1.41

1.5

52.51

59.30

ug/l

0.83

506

Short Achilles tendon (acquired)

165

1.59

1.41

1.5

57.40

53.38

ug/l

0.18

165

Malignant melanoma, including Hilmo

339

0.62

1.41

1.5

42.69

56.08

ug/l

1.48

339

Disorders of puberty, all

478

0.68

1.41

1.8

1.6

66.53

56.80

ug/l

0.61

478

Neurological diseases, wide definition

780

4240

0.92

1.41

1.5

57.57

61.74

ug/l

1.99

780

4240

Diffuse brain injury

238

0.54

1.40

1.5

1.6

57.66

57.94

ug/l

0.01

238

Rheumatoid arthritis, including avohilmo

169

1996

0.85

1.40

1.5

60.21

59.83

ug/l

0.04

169

1996

Pneumonitis due to solids and liquids

137

0.44

1.39

1.0

1.6

72.41

54.72

ug/l

—

137

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

199

0.50

1.39

1.5

1.6

55.84

54.96

ug/l

—

199

Other symptoms and signs involving the nervous and musculoskeletal systems

365

4083

0.89

1.39

1.5

58.02

59.96

ug/l

0.41

365

4083

Acute alcohol intoxication

151

1799

0.84

1.39

1.3

1.6

58.95

60.25

ug/l

0.12

151

1799

Other local infections of skin and subcutaneous tissue

713

0.74

1.39

1.6

1.5

52.67

59.64

ug/l

0.82

713

Hypokalaemia

410

0.66

1.39

1.5

49.80

58.19

ug/l

0.53

410

Asthma (only as main-diagnosis)

911

5473

0.93

1.37

1.5

57.91

61.74

ug/l

1.80

911

5473

Polyarthrosis

1.95

1.37

1.5

1.4

60.04

57.99

ug/l

0.07

Dislocation, sprain and strain of joints and ligaments of thorax

264

1.45

1.37

1.4

1.6

57.08

53.54

ug/l

0.18

264

Monoarthritis, not elsewhere classified

264

1.45

1.37

1.4

1.6

54.64

57.96

ug/l

0.18

264

Excluding asthma or asthma-COPD overlap

1025

5499

0.93

1.37

1.5

57.07

61.76

ug/l

2.93

1025

5499

Malignant melanoma of skin

249

0.56

1.37

1.5

40.70

56.75

ug/l

1.29

249

Reduction defects of lower limb

0.00

1.36

0.0

1.6

—

53.65

—

Complications of medical and surgical care

596

5838

0.92

1.36

1.5

57.29

60.19

ug/l

0.92

596

5838

Chronic hepatitis, not elsewhere classified

165

0.48

1.35

1.5

1.6

72.72

52.37

ug/l

—

165

Hyperhidrosis

569

0.71

1.35

1.6

1.5

70.37

61.34

ug/l

0.57

569

Symptoms and signs involving the circulatory and respiratory systems

1572

8318

0.95

1.35

1.5

58.10

60.62

ug/l

1.55

1572

8318

Dementia, including avohilmo

144

0.52

1.35

1.8

1.6

53.42

51.80

ug/l

0.06

144

Female infertility, tubal origin

655

1.28

1.35

1.4

1.5

52.58

59.41

ug/l

1.08

655

Accidental poisoning by and exposure to alcohol

356

0.64

1.35

1.7

1.6

52.34

56.97

ug/l

0.26

356

Drug-induced neutropenia

209

0.52

1.34

1.4

1.5

56.60

55.62

ug/l

0.05

209

Pain in joint

826

4704

1.08

1.34

1.5

57.38

60.87

ug/l

1.60

826

4704

Endometriosis of pelvic peritoneum

352

2860

1.12

1.34

1.4

1.5

62.92

60.63

ug/l

0.45

352

2860

Benign neoplasm of thyroid gland

128

1.65

1.33

1.3

1.5

51.84

49.18

ug/l

0.16

128

Other diseases of liver

799

0.76

1.33

1.4

1.5

55.54

61.15

ug/l

0.47

799

Other (seronegative) rheumatoid arthritis, wide

742

0.75

1.33

1.4

1.5

60.88

59.67

ug/l

0.06

742

Other infectious diseases

345

0.64

1.32

1.2

1.6

63.82

58.15

ug/l

0.30

345

Arterial embolism and thrombosis of lower extremity artery

0.00

1.32

0.0

1.7

—

51.03

—

Open bite that required surgery (Lefort1 or BSSO)

235

1.49

1.32

1.4

1.6

54.94

54.60

ug/l

0.02

235

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1258

8430

0.94

1.32

1.7

1.5

60.14

60.17

ug/l

0.01

1258

8430

Acute bronchitis

331

3637

0.89

1.31

1.5

51.86

59.92

ug/l

4.28

331

3637

Molar incisor enamel hypoplasia

917

0.78

1.31

1.6

70.23

60.23

ug/l

0.53

917

Seborrhoeic dermatitis

568

0.72

1.31

1.6

1.5

63.62

59.68

ug/l

0.20

568

Other malignant neoplasms of skin (=non-melanoma skin cancer)

276

0.66

1.30

1.6

1.5

57.79

56.44

ug/l

0.08

276

Contact with sharp object, undetermined intent

244

0.57

1.30

1.4

1.6

56.79

56.87

ug/l

0.00

244

Non-ischemic cardiomyopathy

195

0.57

1.30

1.4

1.5

60.72

56.67

ug/l

0.09

195

Problems related to lifestyle

154

1815

0.84

1.30

1.5

58.25

60.16

ug/l

0.19

154

1815

Supplementary factors related to causes of morbidity and mortality classified elsewhere

293

3302

0.89

1.29

1.4

1.5

62.60

59.90

ug/l

0.44

293

3302

LSIL lesion of the vagina

133

0.45

1.29

1.7

1.5

41.47

56.19

ug/l

—

133

Chronic viral hepatitis

577

0.72

1.29

1.3

1.5

52.44

59.52

ug/l

0.54

577

Cerebral aneurysm, nonruptured

193

0.52

1.29

1.2

1.5

54.93

55.72

ug/l

—

193

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

177

2065

0.86

1.29

1.4

1.5

57.15

59.70

ug/l

0.41

177

2065

Sequelae of injuries of head

281

0.60

1.29

1.2

1.6

63.89

57.16

ug/l

0.33

281

Congenital deformities of hip

315

0.62

1.28

1.3

1.5

79.16

58.62

ug/l

0.34

315

Additional codes for the location of defect, injury or illness

437

0.68

1.28

1.4

1.5

61.52

58.42

ug/l

0.12

437

Benign neoplasm: Sigmoid colon

161

1.55

1.28

1.5

56.12

52.37

ug/l

0.20

161

Lung diseases due to external agents

231

0.56

1.28

1.1

1.5

64.42

57.48

ug/l

0.22

231

Scarlet fever

1.86

1.28

1.6

1.5

62.23

45.53

ug/l

0.76

Asthma, including avohilmo

1538

8926

0.95

1.28

1.5

58.78

60.31

ug/l

0.67

1538

8926

Paranoid personality disorder

191

0.52

1.27

1.5

54.38

56.20

ug/l

—

191

Cervicocranial syndrome

815

0.77

1.27

1.5

66.66

61.71

ug/l

0.33

815

Fetus and newborn affected by complications of placenta, cord and membranes

2.53

1.27

1.3

1.6

58.83

47.26

ug/l

—

Pedestrian injured in transport accident

598

0.73

1.26

1.3

1.6

61.72

60.95

ug/l

0.04

598

Other and unspecified local infections of skin and subcutaneous tissue

701

0.75

1.26

1.6

1.5

52.67

59.65

ug/l

0.82

701

Type of accident

262

2967

0.88

1.26

1.4

1.5

61.83

59.66

ug/l

0.31

262

2967

Fracture of lumbar spine and pelvis

924

0.79

1.26

1.5

1.6

55.49

60.43

ug/l

0.49

924

Coxarthrosis, primary

212

0.59

1.25

1.5

53.47

57.21

ug/l

0.16

212

DVT of lower extremities

552

0.72

1.25

1.6

1.5

47.13

58.33

ug/l

2.05

552

Other or unspecified ileus, impaction or obstruction

340

0.65

1.25

1.5

76.05

60.30

ug/l

0.69

340

Nontoxic goitre/thyroid nodule

1103

0.81

1.25

1.5

63.46

60.78

ug/l

0.25

1103

Abscess of anal and rectal regions

551

0.72

1.25

1.4

1.6

65.22

59.09

ug/l

0.32

551

Tularaemia, including avohilmo

131

1.62

1.24

1.6

1.5

46.46

54.15

ug/l

0.95

131

Smoking dependency

564

1.28

1.24

1.4

1.5

55.86

59.72

ug/l

0.35

564

Asthma and allergy

282

3129

0.88

1.24

1.5

59.18

61.44

ug/l

0.37

282

3129

Sicca syndrome [Sjögren]

363

0.66

1.24

1.6

1.5

59.73

60.19

ug/l

0.01

363

Stomatitis and related lesions

199

2291

0.87

1.24

1.5

58.30

60.12

ug/l

0.24

199

2291

Other and unspecified disorders of skin and subcutaneous tissue

290

0.62

1.23

1.5

1.6

48.46

57.87

ug/l

0.54

290

Chronic sinusitis

390

4304

0.90

1.23

1.5

57.29

60.15

ug/l

0.75

390

4304

Other bacterial intestinal infections

967

0.79

1.23

1.5

51.13

59.82

ug/l

1.94

967

Other otitis externa (chronic)

491

0.71

1.22

1.2

1.5

58.51

60.42

ug/l

0.08

491

Pseudomembranous colitis

2.19

1.22

1.3

1.4

94.91

52.42

ug/l

—

Hyperlipidaemia, other/unspecified

304

0.65

1.22

1.6

1.5

80.54

58.08

ug/l

0.68

304

Asthma (mode)

984

5512

0.94

1.22

1.5

58.28

61.76

ug/l

1.61

984

5512

Eclampsia

2.20

1.21

1.5

56.76

54.96

ug/l

—

Sequelae of injuries of neck and trunk

141

0.49

1.21

1.6

55.57

51.61

ug/l

—

141

Gastroduodenal ulcer

348

0.66

1.21

1.2

1.5

49.24

57.55

ug/l

0.50

348

Other superficial mycoses, including avohilmo

162

1887

0.85

1.20

1.5

68.62

59.86

ug/l

1.20

162

1887

Intestinal stricture

696

0.76

1.20

1.4

1.5

61.21

59.97

ug/l

0.07

696

Acute alcohol intoxication, ICD10

151

1771

0.85

1.20

1.3

1.6

58.95

59.96

ug/l

0.09

151

1771

Insulin, intermediate and long-acting

261

2842

0.88

1.20

1.5

61.77

59.80

ug/l

0.27

261

2842

Nasal polyp

718

0.76

1.20

1.4

1.5

51.26

60.68

ug/l

1.61

718

Hypo-osmolality and hyponatraemia

249

0.60

1.20

1.3

1.5

99.02

55.57

ug/l

1.03

249

Malignant melanoma

300

0.63

1.20

1.5

45.69

55.68

ug/l

0.93

300

Other symptoms and signs involving the digestive system and abdomen

130

1091

1.19

1.20

1.4

1.5

64.53

60.25

ug/l

0.48

130

1091

Unspecified abortion

238

0.59

1.19

1.7

1.4

53.07

59.95

ug/l

0.31

238

Other disorders of veins

215

1847

1.15

1.19

1.5

60.30

59.25

ug/l

0.13

215

1847

Autonomic disorders

167

0.53

1.19

1.9

1.6

76.72

52.67

ug/l

—

167

Misadventures to patients during surgical and medical care

107

882

1.22

1.19

1.5

59.89

59.86

ug/l

0.00

107

882

Asthma and allergy, excluding more controls

282

3120

0.89

1.19

1.5

59.18

61.64

ug/l

0.42

282

3120

Explicit Sepsis, including avohilmo

320

2596

1.12

1.19

1.7

1.5

56.90

59.22

ug/l

0.54

320

2596

Other neurotic disorders

168

0.53

1.18

1.2

1.6

83.30

54.32

ug/l

—

168

Use of biperiden

168

0.53

1.18

1.2

1.6

48.47

54.07

ug/l

—

168

Diseases of the musculoskeletal system and connective tissue

1165

6191

0.94

1.17

1.5

58.60

60.79

ug/l

0.88

1165

6191

Psoriasis

140

1649

0.85

1.17

1.6

1.5

49.00

59.95

ug/l

2.94

140

1649

Malignant neoplasm of bronchus and lung

0.00

1.17

0.0

1.3

—

46.11

—

Xerosis cutis

1.95

1.17

1.5

1.7

51.37

49.99

ug/l

0.04

Haemolytic anaemias

236

0.59

1.17

1.4

1.6

74.33

54.09

ug/l

0.61

236

Wilms' tumor, including Hilmo

0.00

1.17

0.0

1.6

—

52.50

—

Juvenile cataract

0.00

1.16

0.0

1.5

—

56.77

—

Anxiety (asthma-related co-morbidities)

1014

8182

0.94

1.16

1.5

58.66

60.21

ug/l

0.59

1014

8182

Cholecystitis

393

0.69

1.16

1.5

43.55

58.70

ug/l

1.89

393

Paralytic ileus and intestinal obstruction

578

0.74

1.16

1.4

1.5

64.64

60.94

ug/l

0.19

578

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

128

0.47

1.16

1.5

1.6

54.00

53.82

ug/l

—

128

ILD, hospital admissions

127

0.47

1.16

1.5

1.6

55.10

51.80

ug/l

—

127

Other interstitial pulmonary diseases

127

0.47

1.16

1.5

1.6

55.10

51.80

ug/l

—

127

Interstitial lung disease

127

0.47

1.16

1.5

1.6

55.10

51.80

ug/l

—

127

Interstitial lung disease endpoints

127

0.47

1.16

1.5

1.6

55.10

51.80

ug/l

—

127

Secondary parkinsonism, excluding more controls

0.00

1.16

0.0

1.6

—

52.09

—

Diseases of inner ear

210

2293

0.87

1.16

1.4

1.5

54.02

59.46

ug/l

1.38

210

2293

Hallux rigidus

128

0.47

1.16

1.3

1.6

38.84

55.98

ug/l

—

128

Cysts of oral region, not elsewhere classified

351

1.35

1.16

1.7

1.6

52.65

55.96

ug/l

0.26

351

Basal cell carcinoma

245

0.67

1.16

1.5

58.89

56.16

ug/l

0.15

245

Hypertrophic disorders of skin

879

0.79

1.15

1.5

55.07

60.42

ug/l

0.47

879

Iron deficiency anaemia

357

3161

1.11

1.15

1.6

1.5

61.43

59.80

ug/l

0.28

357

3161

Congenital malformations of the nervous system

390

0.68

1.15

1.5

1.6

68.74

56.77

ug/l

0.52

390

Other and unspecified polyneuropathies, also in other diseases

285

0.63

1.15

1.4

1.6

63.78

57.89

ug/l

0.33

285

Early syphilis

0.00

1.15

0.0

1.6

—

49.46

—

Injury of nerves at wrist and hand level

272

0.62

1.15

1.5

1.6

38.63

56.70

ug/l

2.28

272

Other disorders of adrenal gland

356

0.67

1.15

1.5

65.17

56.60

ug/l

0.52

356

Acute bronchiolitis

113

1218

0.83

1.15

1.7

1.6

61.76

60.64

ug/l

0.11

113

1218

Mental and behavioural disorders associated with the puerperium

285

1.40

1.15

1.5

1.6

55.63

57.04

ug/l

0.09

285

Ventricular septal defect, a heart condition

317

1.37

1.15

1.4

1.5

55.00

57.64

ug/l

0.18

317

Intestinal infectious diseases, including avohilmo, including avohilmo

1482

7837

1.05

1.15

1.5

60.00

60.31

ug/l

0.10

1482

7837

Transient global amnesia

0.00

1.15

0.0

1.6

—

52.93

—

Emotional disorders and disorders of social functioning with onset specific to childhood

180

2020

0.86

1.15

1.5

1.6

57.65

60.32

ug/l

0.35

180

2020

Constitutional tall stature

137

0.49

1.14

1.3

1.5

54.36

57.65

ug/l

—

137

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

131

1510

0.84

1.14

1.5

1.6

61.99

59.18

ug/l

0.28

131

1510

0.00

1.14

0.0

1.6

—

49.81

—

Other disorders of white blood cells

266

1.40

1.14

1.6

46.37

56.74

ug/l

1.14

266

Noninfectious colitis NAS

1187

0.82

1.14

1.5

56.67

60.18

ug/l

0.42

1187

Explicit bacterial Sepsis, including avohilmo

616

1.25

1.14

1.6

1.5

59.88

61.76

ug/l

0.15

616

Primary hyperparathyroidism

154

0.52

1.13

1.3

1.5

70.20

55.71

ug/l

—

154

Cardiac murmurs and other cardiac sounds

180

1544

1.16

1.13

1.6

1.5

62.17

61.84

ug/l

0.03

180

1544

Secondary hypertension

338

0.67

1.13

1.6

1.5

96.13

57.62

ug/l

1.51

338

Gout, FINNGEN

112

0.44

1.12

1.4

1.5

34.92

50.04

ug/l

—

112

Mental and behavioural disorders due to tobacco

573

1.26

1.12

1.4

1.5

55.86

60.28

ug/l

0.42

573

Artificial opening status

114

0.44

1.12

1.8

1.6

48.38

49.81

ug/l

—

114

Atopic dermatitis, strict definition with reimbursement

798

7179

1.07

1.12

1.5

61.97

59.56

ug/l

0.69

798

7179

Papulosquamous disorders

183

2102

0.87

1.12

1.5

50.35

59.59

ug/l

2.90

183

2102

Pre-eclampsia superimposed on chronic hypertension

1.78

1.12

1.7

1.4

52.81

59.32

ug/l

0.22

severe traumatic brain injury, does not include concussion

517

0.73

1.12

1.5

61.15

59.09

ug/l

0.13

517

Colonic or urogenital fistula

145

1694

0.85

1.11

1.5

61.09

59.41

ug/l

0.20

145

1694

Fracture of femur

404

0.71

1.11

1.4

1.6

59.43

59.72

ug/l

0.01

404

Varicose veins

155

1001

1.17

1.11

1.5

59.24

59.88

ug/l

0.07

155

1001

Abnormal involuntary movements

920

0.80

1.11

1.4

1.5

65.47

60.08

ug/l

0.39

920

Impingement syndrome of shoulder

306

0.65

1.11

1.2

1.5

52.59

58.17

ug/l

0.33

306

Other and unspecified injuries of head

458

0.72

1.11

1.6

67.14

59.02

ug/l

0.41

458

Other fall from one level to another

253

2839

0.89

1.10

1.5

1.6

53.67

60.15

ug/l

1.97

253

2839

Benign neoplasm: Skin, unspecified

201

1.45

1.10

1.7

1.6

64.56

53.81

ug/l

0.42

201

Viral infections of central nervous system, not elsewhere classified/unspecified

1.84

1.10

1.8

1.5

52.63

49.34

ug/l

0.13

Habit and impulse disorders

181

0.55

1.10

1.5

1.6

55.56

55.57

ug/l

—

181

Chronic ulcer of skin, not elsewhere classified

137

0.51

1.09

1.4

1.5

56.29

55.19

ug/l

—

137

Other and unspecified nerve root and plexus disorders, also in other diseases

105

1258

0.83

1.09

1.5

62.48

60.92

ug/l

0.12

105

1258

Implicit viral Sepsis, including avohilmo

167

1922

0.87

1.09

1.5

57.38

60.09

ug/l

0.36

167

1922

Rare circulating lymphoid malignancy, including Hilmo

140

0.50

1.09

2.4

1.5

51.93

53.20

ug/l

—

140

Urethral stricture

2.38

1.09

1.2

1.5

67.77

63.15

ug/l

—

Other adrenocortical overactivity

121

0.48

1.09

1.3

1.5

59.75

52.58

ug/l

—

121

Scar conditions and fibrosis of skin

432

0.71

1.08

1.4

1.5

52.00

59.58

ug/l

0.67

432

Other noninflammatory disorders of uterus, except cervix

488

0.78

1.08

1.6

1.5

57.46

59.45

ug/l

0.14

488

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

181

0.55

1.08

1.1

1.5

59.89

55.06

ug/l

—

181

Other disorders of patella

162

1869

0.86

1.07

1.5

60.71

60.16

ug/l

0.06

162

1869

Varicella [chickenpox], including avohilmo

523

0.74

1.07

1.7

1.6

58.57

58.35

ug/l

0.01

523

Hypoplasia of dental enamel , including avohilmo

855

0.80

1.07

1.6

71.29

60.73

ug/l

0.53

855

Enthesopathies of lower limb, excluding foot

134

1569

0.85

1.07

1.4

1.5

59.39

59.95

ug/l

0.06

134

1569

Other/unspecified rheumatoid arthritis

315

0.67

1.07

1.4

1.5

72.33

58.16

ug/l

0.46

315

Other chronic obstructive pulmonary disease, including avohilmo

506

0.76

1.07

1.5

60.68

60.35

ug/l

0.02

506

Tic and related disorders

264

0.63

1.07

1.5

1.6

70.79

57.11

ug/l

0.77

264

Benign thyroid growths and nodules

113

1247

0.84

1.06

1.5

64.52

60.21

ug/l

0.50

113

1247

Other contact dermatitis

822

1.21

1.06

1.4

1.6

60.41

59.73

ug/l

0.05

822

Foreign body entering into or through eye or natural orifice

534

0.75

1.06

1.7

1.6

55.93

59.22

ug/l

0.22

534

Candidiasis

136

1587

0.85

1.06

1.6

1.5

56.51

60.51

ug/l

0.48

136

1587

Other septicaemia, including avohilmo

135

1481

0.85

1.06

1.5

1.6

62.47

59.88

ug/l

0.33

135

1481

Other extrapyramidal and movement disorders in other diseases

101

1208

0.83

1.04

1.4

1.5

55.27

60.21

ug/l

0.74

101

1208

Hypothyroidism, strict autoimmune

1234

7686

1.05

1.04

1.5

58.40

60.40

ug/l

0.76

1234

7686

Bicornuate uterus

172

1.50

1.04

1.5

56.34

54.23

ug/l

0.10

172

Unicornuate uterus

108

1.68

1.04

1.4

1.6

48.67

52.25

ug/l

0.16

108

Glomerulonephritis

441

0.72

1.04

1.5

78.08

57.86

ug/l

0.83

441

Congenital malformations, deformations and chromosomal abnormalities

1043

9354

1.06

1.04

1.5

61.98

59.88

ug/l

0.72

1043

9354

Major coronary heart disease event excluding revascularizations

176

0.64

1.04

1.5

60.68

55.91

ug/l

0.25

176

Malignant neoplasm of cervix uteri

239

0.62

1.04

1.2

1.5

66.25

57.16

ug/l

0.43

239

Other mycoses, not elsewhere classified/unspecified, including avohilmo

151

0.52

1.03

1.3

1.6

111.76

52.32

ug/l

—

151

Unspecified urinary incontinence

429

0.72

1.03

1.6

64.47

57.22

ug/l

0.48

429

Ménière disease

228

0.61

1.03

1.4

1.5

47.52

58.29

ug/l

0.48

228

Other bursopathies

429

0.72

1.03

1.4

1.6

50.23

58.54

ug/l

0.47

429

Chronic pancreatitis

147

0.54

1.03

1.3

1.6

46.87

51.15

ug/l

—

147

Other misadventures during surgical and medical care

130

1.55

1.03

1.4

1.5

50.62

53.47

ug/l

0.17

130

Other and unspecified disorders of psychological development

171

0.56

1.03

1.4

1.5

82.60

54.89

ug/l

—

171

Use of teriflunomide

106

0.47

1.02

1.6

1.5

52.80

51.78

ug/l

—

106

Diseases of appendix

837

7945

0.94

1.02

1.5

61.89

60.09

ug/l

0.58

837

7945

Gastrointestinal diseases

1209

6381

0.95

1.02

1.5

58.42

60.24

ug/l

0.76

1209

6381

Scissor bite

376

0.70

1.02

1.6

58.32

58.82

ug/l

0.03

376

Striking against or struck by other objects

383

4180

0.91

1.02

1.5

58.38

59.86

ug/l

0.32

383

4180

Other congenital malformations, including avohilmo

186

2111

0.88

1.01

1.5

1.6

55.47

59.97

ug/l

0.85

186

2111

Trigeminal neuralgia

322

0.68

1.01

1.9

1.5

53.97

56.90

ug/l

0.16

322

Seborrhoeic keratosis

377

1.30

1.00

1.5

70.08

57.36

ug/l

1.10

377

Chronic conjunctivitis

201

0.59

1.00

1.5

1.6

55.43

53.61

ug/l

0.05

201

Acute generalized exanthematous pustulosis

368

0.70

1.00

1.6

73.58

57.82

ug/l

1.13

368

Congenital absence of the uterus

0.00

1.00

0.0

1.6

—

54.25

—

Other abnormal findings of blood chemistry

333

0.69

1.00

1.5

59.19

58.09

ug/l

0.05

333

Other diseases of the digestive system

1083

0.83

1.00

1.5

59.88

58.68

ug/l

0.10

1083

Cramp and spasm

414

0.72

1.00

1.3

1.6

55.60

56.93

ug/l

0.06

414

Other embolism and thrombosis

472

0.74

1.00

1.4

1.5

59.38

57.83

ug/l

0.10

472

Cellulitis

144

1664

0.86

0.99

1.6

1.5

56.95

60.57

ug/l

0.52

144

1664

L04AD Calcineurin inhibitors

629

0.78

0.99

1.6

1.5

81.72

59.87

ug/l

1.57

629

Malignant neoplasm of cervix uteri, including Hilmo

284

0.66

0.99

1.2

1.5

71.00

57.62

ug/l

0.92

284

Viral pneumonia (known virus, not influenza)

134

0.52

0.99

1.7

1.6

41.60

53.54

ug/l

—

134

Ventral hernia

746

1.21

0.99

1.4

1.5

67.38

59.97

ug/l

0.44

746

Nephrotic syndrome

158

0.57

0.98

1.4

1.6

128.77

54.54

ug/l

—

158

Disturbances of smell and taste

157

0.57

0.98

1.4

1.5

64.27

56.46

ug/l

—

157

Lichen sclerosus et atrophicus

494

1.26

0.98

1.4

1.5

60.33

58.87

ug/l

0.11

494

Procedures for purposes other than remedying health state

161

0.56

0.98

1.3

1.5

48.68

54.22

ug/l

—

161

Raynaud syndrome

1046

0.83

0.98

1.4

1.5

69.70

60.76

ug/l

0.78

1046

563

5998

0.93

0.98

1.5

54.88

60.33

ug/l

3.12

563

5998

Asthma-related pneumonia

198

2229

0.88

0.98

1.5

55.76

59.87

ug/l

0.81

198

2229

Dependence on enabling machines and devices, not elsewhere classified

0.00

0.97

0.0

1.6

—

48.73

—

Migraine with aura, drug-induced

1.76

0.97

1.3

1.6

53.36

50.03

ug/l

0.18

Allergic urticaria

100

1185

0.84

0.97

1.5

1.6

61.31

60.29

ug/l

0.09

100

1185

Myopia

222

2485

0.89

0.97

1.5

1.6

57.64

59.97

ug/l

0.36

222

2485

Other symptoms and signs involving general sensations and perceptions

295

0.67

0.97

1.5

1.6

47.64

55.94

ug/l

0.51

295

Caught, crushed, jammed or pinched in or between objects

536

0.76

0.96

1.5

1.6

61.51

58.44

ug/l

0.14

536

Spinal osteochondrosis

1.71

0.96

1.4

1.6

56.12

48.94

ug/l

0.39

Ingrowing nail

422

0.73

0.96

1.4

1.5

64.31

59.44

ug/l

0.21

422

Oligomenorrhoea

898

0.82

0.95

1.5

1.6

61.79

60.72

ug/l

0.08

898

Nonalcoholic steatohepatitis

0.00

0.95

0.0

1.5

—

50.78

—

Other diseases of the respiratory system

353

0.71

0.95

1.6

1.5

59.10

56.92

ug/l

0.10

353

Other respiratory disorders and diseases

353

0.71

0.95

1.6

1.5

59.10

56.92

ug/l

0.10

353

Urticaria

424

4595

0.92

0.95

1.4

1.5

60.12

60.60

ug/l

0.08

424

4595

Crohn's disease of large intestine

512

0.76

0.95

1.6

1.5

58.36

59.50

ug/l

0.07

512

Cholecystectomy

444

4082

0.92

0.95

1.5

51.08

59.99

ug/l

5.29

444

4082

Nystagmus and other irregular eye movements

117

0.51

0.95

1.3

1.6

44.66

51.24

ug/l

—

117

Acute suppurative otitis media

670

6651

0.94

0.95

1.6

1.5

56.60

60.10

ug/l

1.41

670

6651

Balanced rearrangements and structural markers, not elsewhere classified

1.70

0.95

1.6

1.5

52.86

55.99

ug/l

0.11

Dermatophytosis, including avohilmo

655

6845

0.94

0.95

1.5

61.95

60.26

ug/l

0.43

655

6845

Qualitative platelet defects

2.27

0.94

1.8

1.6

39.75

57.27

ug/l

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1219

8589

0.95

0.94

1.5

58.25

60.31

ug/l

0.79

1219

8589

Protozoal diseases, including avohilmo

117

0.51

0.94

1.8

1.6

60.92

51.30

ug/l

—

117

Gluteal tendinitis

185

0.59

0.94

1.5

1.6

71.53

55.31

ug/l

0.40

185

Appendicitis, broad definition

835

7929

0.94

1.5

61.83

60.09

ug/l

0.56

835

7929

Obesity due to excess calories

765

7206

1.06

0.94

1.5

42.63

62.56

ug/l

58.04

765

7206

Diabetic retinopathy, excluding more controls

101

671

0.84

0.94

1.5

1.6

65.50

49.21

ug/l

2.31

101

671

Other/unspecified disorders of vestibular function

144

0.55

0.93

1.4

1.6

39.41

51.70

ug/l

—

144

Carcinoma in situ of breast, intraductal

120

0.50

0.93

1.3

1.5

81.90

58.30

ug/l

—

120

Diagnoses used for exclusion with ILD

601

0.78

0.93

1.2

1.5

65.63

59.29

ug/l

0.43

601

Other disorders of the genitourinary system

269

0.67

0.93

1.4

1.5

58.59

57.35

ug/l

0.05

269

Fissure and fistula of anal and rectal regions

142

1632

0.87

0.93

1.5

61.22

59.14

ug/l

0.26

142

1632

Gastric ulcer

257

0.66

0.93

1.2

1.6

54.49

57.84

ug/l

0.13

257

Universal erythroderma, KELA reimbursement

1.74

0.92

1.2

1.5

50.14

59.51

ug/l

—

Viral pneumonia

898

0.82

0.92

1.4

1.5

51.11

60.52

ug/l

1.58

898

Other disorders of eyelid

786

0.82

0.92

1.4

1.5

62.06

59.47

ug/l

0.19

786

GASTRO-related operations

1521

7301

1.05

0.92

1.5

59.99

60.21

ug/l

0.06

1521

7301

Any gastric operation

1521

7301

1.05

0.92

1.5

59.99

60.21

ug/l

0.06

1521

7301

Symptoms and signs involving emotional state

429

0.74

0.92

1.4

1.5

60.05

60.59

ug/l

0.03

429

Cerebral palsy and other paralytic syndromes

721

0.80

0.91

1.3

1.5

56.97

60.41

ug/l

0.26

721

Cerebral cysts

720

0.80

0.91

1.3

1.5

68.42

60.08

ug/l

0.90

720

Acute lymphocytic leukaemia, including Hilmo

101

0.48

0.91

3.0

1.5

74.22

50.39

ug/l

—

101

Acute lymphocytic leukaemia

101

0.48

0.91

3.0

1.5

74.22

50.39

ug/l

—

101

Acute lymphocytic leukaemia, helper endpoint

101

0.48

0.91

3.0

1.5

74.22

50.39

ug/l

—

101

Mandibular retrognathia AND surgery (BSSO)

358

1.30

0.91

1.4

1.6

54.07

58.42

ug/l

0.39

358

Other and unspecified vaccines and biological substances

104

0.47

0.91

1.2

1.6

73.14

51.39

ug/l

—

104

Coagulation defects, purpura and other haemorrhagic conditions

191

1695

1.13

0.91

1.5

56.72

60.13

ug/l

0.61

191

1695

Hypothyroidism, other/unspecified

1373

8627

1.05

0.90

1.5

58.93

60.29

ug/l

0.48

1373

8627

Inflammatory diseases of female pelvic organs

1386

9073

1.05

0.90

1.5

59.66

60.11

ug/l

0.14

1386

9073

Other specified congenital malformation syndromes affecting multiple systems

194

0.61

0.90

1.6

55.45

52.80

ug/l

0.10

194

Dementia

126

0.60

0.90

1.8

1.6

53.42

51.18

ug/l

0.09

126

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS